Necrotizing enterocolitis is the most common gastrointestinal emergency of preterm neonates: an acute, patchy inflammatory necrosis of the small bowel and colon that can progress within hours to transmural necrosis, perforation, peritonitis and septic shock. It is multifactorial rather than Mendelian. The dominant risk factor is prematurity itself, which leaves the intestine with an immature epithelial barrier, an immature innate immune set-point, and immature microvascular autoregulation. On that substrate, abnormal microbial colonization of the preterm gut supplies the luminal microbial ligands that the immature epithelium over-reads, chiefly through the lipopolysaccharide receptor TLR4, which is expressed at higher levels in the premature than the full-term gut. TLR4 signalling in the epithelium drives enterocyte apoptosis and blocks mucosal restitution, while TLR4 signalling in the intestinal endothelium lowers endothelial nitric oxide synthase output and reduces mesenteric perfusion. The result is a self-amplifying loop of barrier failure, bacterial and lipopolysaccharide translocation, mucosal cytokine release and microcirculatory ischemia that produces the coagulative necrosis and intramural gas (pneumatosis intestinalis) by which the disease is recognized radiographically. Human milk is the best-established protective exposure and formula feeding the best-established feeding risk. Survivors carry a durable burden of intestinal stricture, short bowel syndrome and neurodevelopmental impairment, the latter linked to the same systemic inflammatory response that injures the gut. Severity is graded with the Bell staging system.
Ask a research question about Necrotizing Enterocolitis. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: Necrotizing Enterocolitis
creation_date: "2026-09-29T00:00:00Z"
category: Complex
categories:
- Gastrointestinal Disease
- Neonatal Disorder
- Disorder of Prematurity
synonyms:
- NEC
- necrotising enterocolitis
- neonatal necrotizing enterocolitis
- necrotizing enterocolitis in fetus or newborn
description: >-
Necrotizing enterocolitis is the most common gastrointestinal emergency of
preterm neonates: an acute, patchy inflammatory necrosis of the small bowel
and colon that can progress within hours to transmural necrosis, perforation,
peritonitis and septic shock. It is multifactorial rather than Mendelian. The
dominant risk factor is prematurity itself, which leaves the intestine with an
immature epithelial barrier, an immature innate immune set-point, and immature
microvascular autoregulation. On that substrate, abnormal microbial
colonization of the preterm gut supplies the luminal microbial ligands that
the immature epithelium over-reads, chiefly through the lipopolysaccharide
receptor TLR4, which is expressed at higher levels in the premature than the
full-term gut. TLR4 signalling in the epithelium drives enterocyte apoptosis
and blocks mucosal restitution, while TLR4 signalling in the intestinal
endothelium lowers endothelial nitric oxide synthase output and reduces
mesenteric perfusion. The result is a self-amplifying loop of barrier failure,
bacterial and lipopolysaccharide translocation, mucosal cytokine release and
microcirculatory ischemia that produces the coagulative necrosis and
intramural gas (pneumatosis intestinalis) by which the disease is recognized
radiographically. Human milk is the best-established protective exposure and
formula feeding the best-established feeding risk. Survivors carry a durable
burden of intestinal stricture, short bowel syndrome and neurodevelopmental
impairment, the latter linked to the same systemic inflammatory response that
injures the gut. Severity is graded with the Bell staging system.
parents:
- Gastrointestinal Disease
- Disorder of prematurity
disease_term:
preferred_term: necrotizing enterocolitis
term:
id: MONDO:0005313
label: necrotizing enterocolitis
notes: >-
Not a Mendelian disease and deliberately carries no *causative* `genetic:`
record. The susceptibility literature was reviewed and one record is curated
from it, SIGIRR, as `relationship_type: SUSCEPTIBILITY` - the only NEC locus
with both human loss-of-function variants and functional corroboration that
the variants disinhibit TLR4 signalling. It does not meet a causal bar and is
not claimed to: the supporting cohort is 17 sequenced infants with no matched
preterm control group, so the variant share among cases is not an effect
estimate. The other loci reported in the candidate-gene literature surveyed
here (NFKB1, LY96, IL18, and TLR4 itself) are not curated, because nothing
read for this entry supplies a quotable human result for them and because the
asymmetry is itself the finding: the pathway is genetically implicated through
its regulator rather than through the receptor that carries the mechanism. No
external body has classified any NEC gene pair, so no `gene_disease_validity`
is recorded anywhere in this entry. Whether NEC has a heritable component
distinct from the heritability of prematurity is recorded as an open gap
(`discussions#nec_heritable_component`) rather than resolved here.
Scope relative to MONDO: `MONDO:0004639 perinatal necrotizing enterocolitis`
is MONDO's only descendant of the anchor term and names the same clinical
entity by its onset window; it is not curated as a separate `has_subtypes`
row because the clinically load-bearing stratification in this disease is
medical versus surgical NEC (captured in `stages:` and in the prevalence and
outcome records), not perinatal versus non-perinatal onset. Spontaneous
intestinal perforation is a distinct entity that is repeatedly pooled with
NEC in surgical series, including the peritoneal-drainage meta-analysis cited
under treatments; that pooling is a limitation of the evidence rather than a
claim of identity.
No `conforms_to` target was found for the ischemia-reperfusion arm: `just
list-modules` and `ls kb/modules/` return no ischemia, reperfusion or
mesenteric-perfusion module, so the microcirculatory nodes here are curated
de novo. `gut_dysbiosis` was considered for the colonization nodes and
rejected: that module is an aging hallmark scoped to age-associated
microbiota drift feeding inflammaging, which is the wrong direction of life
course for neonatal colonization. `epithelial_barrier_dysfunction` was also
rejected because it models the epithelial-barrier hypothesis of type 2
allergic disease and terminates in IgE class switch and the atopic march.
definitions:
- name: Bell staging of necrotizing enterocolitis
definition_type: DIAGNOSTIC_CRITERIA
derivation_basis: ESTABLISHED_CRITERIA
description: >-
Clinical staging system that grades NEC by systemic signs, intestinal signs
and radiographic findings, and that ties each grade to a management tier.
Proposed by Bell and colleagues in 1978 and subsequently modified; it
remains the reference stratification used by trials, registries and
surgical series, and is the basis of the medical (stage II) versus surgical
(stage III) split used throughout this entry.
scope: Preterm and term neonates with suspected necrotizing enterocolitis
evidence:
- reference: PMID:413500
reference_title: "Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: PRIMARY_RESULT
snippet: "A method of clinical staging for infants with necrotizing enterocolitis (NEC) is proposed."
explanation: >-
The originating publication of the staging system this definition records.
- reference: PMID:413500
reference_title: "Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: PRIMARY_RESULT
snippet: >-
For Stage I infants, vigorous diagnostic and supportive measures are
appropriate. Stage II infants are treated medically, including parenteral
and gavage aminoglycoside antibiotic, and Stage III patients require
operation.
explanation: >-
States the stage-to-management mapping that makes the staging system a
therapeutic and not merely descriptive classification.
stages:
- name: Bell stage I
description: >-
Mild or suspected NEC. Mild systemic and intestinal signs with nonspecific
radiographs; managed by close observation and withholding enteral feeds.
evidence:
- reference: PMID:27534694
reference_title: "Necrotizing enterocolitis: new insights into pathogenesis and mechanisms."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: "Mild NEC, suspected NEC | Mild systemic signs and intestinal signs | Nonspecific"
explanation: >-
The review's Bell staging table row defining stage I severity and
radiographic findings.
- name: Bell stage II
description: >-
Moderate NEC, the medically managed tier. Prominent abdominal distension,
tenderness and wall oedema with thrombocytopenia and metabolic acidosis, plus
pneumatosis intestinalis or portal venous gas on radiography.
evidence:
- reference: PMID:27534694
reference_title: "Necrotizing enterocolitis: new insights into pathogenesis and mechanisms."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
Moderate systemic signs with prominent abdominal distension, abdominal
tenderness and wall oedema Thrombocytopenia and metabolic acidosis |
Pneumatosis intestinalis, portal venous gas
explanation: >-
The review's Bell staging table row defining the stage II clinical and
radiographic criteria.
- name: Bell stage III
description: >-
Advanced NEC, the surgical tier. Worsening stage II findings plus
hypotension, peritonitis, severe metabolic acidosis and shock, with
pneumoperitoneum on radiography; managed by laparotomy and resection of
necrotic bowel, or peritoneal drainage in selected infants.
evidence:
- reference: PMID:27534694
reference_title: "Necrotizing enterocolitis: new insights into pathogenesis and mechanisms."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
Worsening stage II signs and symptoms plus hypotension Signs of
peritonitis Severe metabolic acidosis and shock.
explanation: >-
The review's Bell staging table row defining stage III, the tier at which
operative intervention is indicated.
pathophysiology:
- name: Intestinal Immaturity of Prematurity
biological_scale: TISSUE
description: >-
Preterm birth interrupts intestinal maturation, leaving an epithelium with
incomplete junctional and mucus barrier function, an innate immune
set-point tuned to over-respond to microbial ligands, and immature
microvascular and neuromuscular control. This is the substrate on which
every other node in this entry acts, and it is why gestational age is the
dominant risk factor for NEC rather than any single exposure.
biological_processes:
- preferred_term: intestinal epithelial cell development
term:
id: GO:0060576
label: intestinal epithelial cell development
modifier: DECREASED
locations:
- preferred_term: small intestine
term:
id: UBERON:0002108
label: small intestine
downstream:
- target: Elevated Intestinal Epithelial TLR4 Expression
description: >-
The immature gut carries the higher TLR4 expression that makes it
hyper-reactive to luminal lipopolysaccharide.
- target: Abnormal Microbial Colonization of the Preterm Gut
description: >-
Prolonged hospitalization, delayed and non-maternal feeding, and broad
antibiotic exposure shape an abnormal colonization trajectory in the
preterm gut.
- target: Impaired Intestinal Microcirculatory Autoregulation
description: >-
Immature vasoregulation leaves mesenteric perfusion poorly able to match
the metabolic demand imposed by enteral feeding.
evidence:
- reference: PMID:40953322
reference_title: "Exploring the Complex Pathophysiology of Necrotizing Enterocolitis in Preterm Neonates."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
We examine key contributing factors, including intestinal vascular
development, mucosal immunity, intestinal regeneration, the enteric
nervous system, and the gut microbiome, highlighting how prematurity
disrupts these processes and predisposes neonates to NEC.
explanation: >-
Names prematurity as the disruption acting across the vascular, immune,
regenerative and microbial axes that the downstream nodes here separate
out.
- reference: PMID:27534694
reference_title: "Necrotizing enterocolitis: new insights into pathogenesis and mechanisms."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
disease onset is thought to be due in part to a baseline increased
reactivity of the premature intestinal mucosa to microbial ligands as
compared with the full-term intestinal mucosa
explanation: >-
States the immature-mucosa hyper-reactivity that this node represents, and
contrasts it explicitly with the full-term gut.
- name: Elevated Intestinal Epithelial TLR4 Expression
biological_scale: MOLECULAR
description: >-
The premature intestinal epithelium expresses TLR4 at higher levels than the
full-term epithelium. This is not incidental: TLR4 has a developmental role
in normal gut morphogenesis, and its prenatal persistence leaves the preterm
epithelium primed to respond to the lipopolysaccharide it will meet once
colonization and feeding begin.
cell_types:
- preferred_term: enterocyte
term:
id: CL:0000584
label: enterocyte
- preferred_term: intestinal epithelial cell
term:
id: CL:0002563
label: intestinal epithelial cell
biological_processes:
- preferred_term: toll-like receptor 4 signaling pathway
term:
id: GO:0034142
label: toll-like receptor 4 signaling pathway
modifier: INCREASED
downstream:
- target: Epithelial TLR4 Hyperactivation by Luminal Lipopolysaccharide
description: >-
High receptor abundance converts a given luminal lipopolysaccharide load
into a larger epithelial signal than the same load would produce in a
term gut.
evidence:
- reference: PMID:35347256
reference_title: "Bench to bedside - new insights into the pathogenesis of necrotizing enterocolitis."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
Central amongst the bacterial signalling receptors implicated in NEC
development is the lipopolysaccharide receptor Toll-like receptor 4
(TLR4), which is expressed at higher levels in the premature gut than in
the full-term gut.
explanation: >-
States both claims this node makes: that TLR4 is the central receptor, and
that its expression is higher in the premature than the full-term gut.
- reference: PMID:17878380
reference_title: "A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
directness: DIRECT
snippet: >-
We now demonstrate that NEC in mice and humans is associated with
increased expression of TLR4 in the intestinal mucosa and that
physiological stressors associated with NEC development, namely, exposure
to LPS and hypoxia, sensitize the murine intestinal epithelium to LPS
through up-regulation of TLR4.
explanation: >-
Measures increased mucosal TLR4 in NEC and shows that the physiological
stressors of NEC further up-regulate it, which is the sensitization this
node asserts.
- name: Abnormal Microbial Colonization of the Preterm Gut
biological_scale: ORGANISM
description: >-
The preterm gut is colonized on an abnormal trajectory. Rather than a
consistent single pathogen, what distinguishes infants who go on to develop
NEC is a shift in community structure that emerges weeks after birth: an
expansion of facultatively anaerobic Gammaproteobacteria and a depletion of
strict anaerobes. No organism is necessary or sufficient, which is why this
node is a community-level state rather than an infection.
locations:
- preferred_term: intestinal mucosa
term:
id: UBERON:0001242
label: intestinal mucosa
notes: >-
Taxa named in the supporting studies are Gammaproteobacteria
(NCBITaxon:1236) and Enterobacteriaceae (NCBITaxon:543) on the expanding
side, Negativicutes and other strict anaerobes on the depleted side, and
Bifidobacterium longum (NCBITaxon:216816) among the taxa reduced before
onset. NCBITaxon terms are not bound in `cell_types`, per the
microbiome-curation rule that microbial taxa are not cell types.
downstream:
- target: Gammaproteobacterial Bloom and Increased Luminal Lipopolysaccharide Load
description: >-
The community shift is what raises the gram-negative share of the
community and therefore the luminal lipopolysaccharide burden.
evidence:
- reference: PMID:26969089
reference_title: "Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: "The microbial community structure in case stools differed significantly from those in control stools. These differences emerged only after the first month of age."
explanation: >-
Prospective case-control stool sequencing in very low birthweight infants
establishes a community-structure difference preceding NEC, and dates its
emergence, which is the community-level claim this node makes.
- reference: PMID:33330904
reference_title: "Necrotizing Enterocolitis and the Microbiome: Current Status and Future Directions."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
evidence suggests that host-microbiota interactions, in which microbial
dysbiosis is followed by loss of barrier integrity, inflammation, and
necrosis, are central to NEC development
explanation: >-
States the dysbiosis-to-barrier-failure-to-necrosis ordering that this
node heads.
- name: Gammaproteobacterial Bloom and Increased Luminal Lipopolysaccharide Load
biological_scale: ORGANISM
description: >-
Expansion of facultatively anaerobic Gammaproteobacteria, largely
Enterobacteriaceae, at the expense of strict anaerobes raises the
gram-negative fraction of the luminal community and with it the
lipopolysaccharide available at the epithelial surface. This is the ligand
supply side of the TLR4 mechanism; the receptor side is the preceding
epithelial node.
chemical_entities:
- preferred_term: lipopolysaccharide
term:
id: CHEBI:16412
label: lipopolysaccharide
modifier: INCREASED
downstream:
- target: Epithelial TLR4 Hyperactivation by Luminal Lipopolysaccharide
description: >-
The raised luminal lipopolysaccharide load is the ligand that engages the
over-expressed epithelial receptor.
evidence:
- reference: PMID:26969089
reference_title: "Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: "the time-by-necrotising-enterocolitis interaction was positively associated with Gammaproteobacteria"
explanation: >-
Names the expanding taxonomic group this node asserts, measured in stool
before NEC onset.
- reference: PMID:33328245
reference_title: "Human milk oligosaccharide DSLNT and gut microbiome in preterm infants predicts necrotising enterocolitis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
Metagenomic sequencing before NEC onset showed significantly lower
relative abundance of Bifidobacterium longum and higher relative
abundance of Enterobacter cloacae in infants with NEC.
explanation: >-
Independent metagenomic replication of the same directional shift at
species level, sampled before onset, with a named Enterobacteriaceae
organism on the expanding side.
- name: Epithelial TLR4 Hyperactivation by Luminal Lipopolysaccharide
biological_scale: CELLULAR
description: >-
Engagement of the abundant epithelial TLR4 by luminal lipopolysaccharide
converts the ligand load into a proinflammatory epithelial response. This
is the convergence point of the two upstream arms - the receptor supplied
by prematurity and the ligand supplied by abnormal colonization - and it is
the step that the protective effect of human milk is thought to act on.
cell_types:
- preferred_term: enterocyte
term:
id: CL:0000584
label: enterocyte
biological_processes:
- preferred_term: cellular response to lipopolysaccharide
term:
id: GO:0071222
label: cellular response to lipopolysaccharide
modifier: INCREASED
downstream:
- target: Enterocyte Apoptosis and Failed Mucosal Restitution
description: >-
TLR4 signalling shifts the epithelium from renewal toward death and
arrested repair.
- target: Mucosal Proinflammatory Cytokine Amplification
description: >-
The same signalling drives the mucosal cytokine output that recruits
myeloid cells and sustains the inflammatory response.
evidence:
- reference: PMID:35347256
reference_title: "Bench to bedside - new insights into the pathogenesis of necrotizing enterocolitis."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
the interaction between bacterial signalling receptors on the premature
intestine and an abnormal gut microbiota incites a pro-inflammatory
response in the intestinal mucosa and its underlying endothelium that
leads to NEC
explanation: >-
States the receptor-plus-microbiota convergence this node represents, and
its proinflammatory output in both mucosa and endothelium.
- reference: PMID:17878380
reference_title: "A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
directness: DIRECT
snippet: "TLR4-mutant C3H/HeJ mice were protected from the development of NEC compared with wild-type C3H/HeOUJ littermates."
explanation: >-
Loss-of-receptor protection in a murine NEC model establishes that
epithelial TLR4 signalling is required rather than merely correlated.
- name: Enterocyte Apoptosis and Failed Mucosal Restitution
conforms_to: intestinal_barrier_dysfunction#Epithelial Stress and Injury
biological_scale: CELLULAR
description: >-
Downstream of TLR4 the epithelium both loses cells to apoptosis and fails to
replace them: migration and proliferation are suppressed, so the denuded
surface is not resurfaced. The lesion is therefore not injury alone but
injury with arrested repair, which is what allows a focal insult to become a
confluent defect.
cell_types:
- preferred_term: enterocyte
term:
id: CL:0000584
label: enterocyte
biological_processes:
- preferred_term: apoptotic process
term:
id: GO:0006915
label: apoptotic process
modifier: INCREASED
- preferred_term: epithelial cell migration
term:
id: GO:0010631
label: epithelial cell migration
modifier: DECREASED
- preferred_term: epithelial cell proliferation
term:
id: GO:0050673
label: epithelial cell proliferation
modifier: DECREASED
downstream:
- target: Intestinal Epithelial Barrier Failure and Bacterial Translocation
description: >-
Unrepaired epithelial loss is the structural basis of the barrier defect.
evidence:
- reference: PMID:17878380
reference_title: "A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair."
supports: SUPPORT
evidence_source: IN_VITRO
directness: DIRECT
snippet: "TLR4 activation in vitro led to increased enterocyte apoptosis and reduced enterocyte migration and proliferation, suggesting a role for TLR4 in intestinal repair."
explanation: >-
Directly measures the three process changes this node binds - apoptosis
up, migration and proliferation down - as consequences of TLR4
activation.
- reference: PMID:25899687
reference_title: "Breast milk protects against the development of necrotizing enterocolitis through inhibition of Toll-like receptor 4 in the intestinal epithelium via activation of the epidermal growth factor receptor."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
directness: INDIRECT
snippet: "The protective effects of breast milk occurred via inhibition of enterocyte apoptosis and restoration of enterocyte proliferation."
explanation: >-
Rescue in the opposite direction: an intervention that protects against
NEC does so by reversing exactly the apoptosis-and-proliferation changes
this node asserts. Graded INDIRECT because the inference runs from
therapeutic reversal back to the mechanism.
- name: Impaired Intestinal Microcirculatory Autoregulation
biological_scale: TISSUE
description: >-
The newborn mesenteric circulation is held in a strongly vasodilated state
by endothelium-derived nitric oxide, which is what keeps oxygen delivery
matched to a rapidly growing gut. That arrangement has little reserve:
endothelial injury shifts the balance toward endothelin-1-mediated
vasoconstriction, and in the preterm infant the shift can be provoked by the
ordinary metabolic demand of an enteral feed.
cell_types:
- preferred_term: endothelial cell
term:
id: CL:0000115
label: endothelial cell
biological_processes:
- preferred_term: nitric oxide biosynthetic process
term:
id: GO:0006809
label: nitric oxide biosynthetic process
modifier: DECREASED
downstream:
- target: Intestinal Microcirculatory Hypoperfusion and Mucosal Ischemia
description: >-
Loss of the vasodilatory set-point is what converts a normal feeding
demand into a perfusion deficit.
evidence:
- reference: PMID:18346531
reference_title: "The neonatal intestinal vasculature: contributing factors to necrotizing enterocolitis."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
In the newborn, this balance heavily favors vasodilation secondary to the
copious production of endothelium-derived nitric oxide (NO), a
circumstance which serves to ensure adequate blood flow and thus oxygen
delivery to the rapidly growing intestine.
explanation: >-
States the nitric-oxide-dependent vasodilatory set-point whose fragility
this node represents.
- reference: PMID:18346531
reference_title: "The neonatal intestinal vasculature: contributing factors to necrotizing enterocolitis."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: "Endothelial cell injury could shift this balance in favor of endothelin (ET)-1-mediated vasoconstriction, leading to intestinal ischemia and tissue injury."
explanation: >-
Names the direction the balance shifts in and the ischemic consequence
that the downstream node carries.
- name: Endothelial TLR4 Activation and Loss of eNOS-Dependent Vasodilation
biological_scale: CELLULAR
description: >-
TLR4 signalling in the intestinal endothelium, not only in the epithelium,
is required for experimental NEC. Endothelial TLR4 activation reduces
endothelial nitric oxide synthase expression through MyD88 and selectively
impairs perfusion of the small intestine, which supplies the mechanism by
which an inflammatory signal produces the ischemia that had otherwise to be
assumed.
cell_types:
- preferred_term: endothelial cell of vascular tree
term:
id: CL:0002139
label: endothelial cell of vascular tree
biological_processes:
- preferred_term: toll-like receptor 4 signaling pathway
term:
id: GO:0034142
label: toll-like receptor 4 signaling pathway
modifier: INCREASED
- preferred_term: endothelial nitric oxide synthase-dependent nitric oxide production
term:
id: GO:0006809
label: nitric oxide biosynthetic process
modifier: DECREASED
downstream:
- target: Intestinal Microcirculatory Hypoperfusion and Mucosal Ischemia
description: >-
Reduced endothelial nitric oxide synthase output is the direct cause of
the perfusion deficit in this arm.
evidence:
- reference: PMID:23650378
reference_title: "Endothelial TLR4 activation impairs intestinal microcirculatory perfusion in necrotizing enterocolitis via eNOS-NO-nitrite signaling."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
directness: DIRECT
snippet: >-
we now show that endothelial TLR4 activation is required for NEC
development and that endothelial TLR4 activation impairs intestinal
perfusion without effects on other organs and reduces eNOS expression via
activation of myeloid differentiation primary response gene 88
explanation: >-
Endothelium-selective TLR4 deletion establishes requirement, gut
selectivity, and the eNOS-lowering mechanism that this node asserts.
- reference: PMID:23650378
reference_title: "Endothelial TLR4 activation impairs intestinal microcirculatory perfusion in necrotizing enterocolitis via eNOS-NO-nitrite signaling."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
directness: INDIRECT
snippet: "NEC severity was significantly increased in eNOS(-/-) mice and decreased upon administration of the phosphodiesterase inhibitor sildenafil, which augments eNOS function."
explanation: >-
Bidirectional genetic and pharmacological manipulation of eNOS moves NEC
severity in opposite directions, supporting eNOS as the effector rather
than a correlate. INDIRECT because the inference runs from severity
modulation back to the perfusion step.
- name: Intestinal Microcirculatory Hypoperfusion and Mucosal Ischemia
biological_scale: TISSUE
description: >-
Convergence of the developmental and inflammatory vascular arms on a
localized perfusion deficit in the small bowel and colon. Ischemia is not
merely a late complication of established inflammation here: the coagulative
character of the necrosis found at surgery is the evidence that it is
upstream, and one current sequential model places feeding-triggered
localized ischemia at the initiating step.
biological_processes:
- preferred_term: response to hypoxia
term:
id: GO:0001666
label: response to hypoxia
modifier: INCREASED
locations:
- preferred_term: wall of small intestine
term:
id: UBERON:0001168
label: wall of small intestine
downstream:
- target: Intestinal Epithelial Barrier Failure and Bacterial Translocation
description: >-
Ischemic epithelium loses barrier function independently of the TLR4
apoptotic arm.
- target: Coagulative Mucosal Necrosis and Intramural Gas Formation
description: >-
Sustained regional ischemia is what produces coagulative rather than
purely inflammatory necrosis.
evidence:
- reference: PMID:18346531
reference_title: "The neonatal intestinal vasculature: contributing factors to necrotizing enterocolitis."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: "Based on the demonstration of coagulation necrosis, it is clear that intestinal ischemia plays a role in the pathogenesis of necrotizing enterocolitis (NEC)."
explanation: >-
Argues from the histological character of the lesion to the presence of
ischemia in the causal chain, which is why this node sits upstream of the
necrosis node rather than beside it.
- reference: PMID:40953322
reference_title: "Exploring the Complex Pathophysiology of Necrotizing Enterocolitis in Preterm Neonates."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
we propose a sequential model of NEC pathogenesis, hypothesizing that
impaired intestinal microcirculation in preterm neonates compromises blood
flow in response to enteral feeding, leading to localized ischemia
explanation: >-
States the feeding-triggered localized-ischemia step explicitly. Cited as
a proposed model, which is how the review frames it.
- name: Intestinal Epithelial Barrier Failure and Bacterial Translocation
conforms_to: intestinal_barrier_dysfunction#Luminal Access and Inflammatory Amplification
biological_scale: TISSUE
description: >-
Once the epithelium is breached, luminal bacteria and lipopolysaccharide
reach the lamina propria, the submucosa and the portal circulation. This is
the amplification step of the disease: the same ligands that started the
epithelial response now reach the immune and vascular compartments directly,
so injury feeds its own cause.
locations:
- preferred_term: intestinal mucosa
term:
id: UBERON:0001242
label: intestinal mucosa
biological_processes:
- preferred_term: tight junction organization
term:
id: GO:0120193
label: tight junction organization
modifier: DECREASED
downstream:
- target: Mucosal Proinflammatory Cytokine Amplification
description: >-
Translocated microbial products engage lamina propria myeloid cells.
- target: Systemic Inflammatory Response and Sepsis
description: >-
Portal and systemic entry of enteric organisms is the route from a local
lesion to bacteraemia.
evidence:
- reference: PMID:17878380
reference_title: "A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: BACKGROUND
snippet: "is characterized by translocation of LPS across the inflamed intestine"
explanation: >-
States translocation of lipopolysaccharide across the inflamed intestine
as a defining feature of the human disease. Graded HUMAN_CLINICAL for the
clinical characterization the sentence makes, with quote_role BACKGROUND
because the citing paper is a murine study restating it.
- reference: PMID:33330904
reference_title: "Necrotizing Enterocolitis and the Microbiome: Current Status and Future Directions."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
evidence suggests that host-microbiota interactions, in which microbial
dysbiosis is followed by loss of barrier integrity, inflammation, and
necrosis, are central to NEC development
explanation: >-
Places loss of barrier integrity between dysbiosis and inflammation, which
is the position this node occupies.
- name: Mucosal Proinflammatory Cytokine Amplification
biological_scale: TISSUE
description: >-
Lamina propria macrophages and recruited neutrophils, engaged by
translocated microbial products and by epithelial signals, release TNF,
interleukin-6, platelet-activating factor and nitric oxide. The output is
large enough to be systemic rather than local, which is what links the
intestinal lesion to the haemodynamic and cerebral consequences.
cell_types:
- preferred_term: macrophage
term:
id: CL:0000235
label: macrophage
- preferred_term: neutrophil
term:
id: CL:0000775
label: neutrophil
biological_processes:
- preferred_term: inflammatory response
term:
id: GO:0006954
label: inflammatory response
modifier: INCREASED
- preferred_term: tumor necrosis factor production
term:
id: GO:0032640
label: tumor necrosis factor production
modifier: INCREASED
downstream:
- target: Coagulative Mucosal Necrosis and Intramural Gas Formation
description: >-
Cytokine and nitric-oxide-mediated tissue injury contributes to the
necrotic lesion alongside ischemia.
- target: Systemic Inflammatory Response and Sepsis
description: >-
The mediator output spills over into a systemic inflammatory state.
- target: Abdominal distention
description: >-
Inflammatory ileus with bowel wall oedema is what produces the distension,
tenderness and wall oedema that the Bell stage II criteria name together.
- target: Feeding difficulties
description: >-
Inflammatory disturbance of motility and gastric emptying presents as
feeding intolerance with raised gastric residuals, which is typically the
first sign.
evidence:
- reference: PMID:27836422
reference_title: "Surgical necrotizing enterocolitis."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
interleukin-6, platelet activating factor, and nitric oxide, claimed to
contribute to a mechanism that leads to hemodynamic instability, tissue
necrosis, and white matter injury
explanation: >-
Names the mediators this node binds and the three consequences its
downstream edges carry: haemodynamic instability, tissue necrosis and
white matter injury.
- reference: PMID:35347256
reference_title: "Bench to bedside - new insights into the pathogenesis of necrotizing enterocolitis."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
incites a pro-inflammatory response in the intestinal mucosa and its
underlying endothelium that leads to NEC
explanation: >-
Locates the proinflammatory response in the mucosa and the underlying
endothelium, and places it causally upstream of NEC.
- name: Coagulative Mucosal Necrosis and Intramural Gas Formation
biological_scale: TISSUE
description: >-
The characteristic lesion: patchy coagulative necrosis of the bowel wall,
with gas generated by luminal organisms tracking into the mucosal,
submucosal and subserosal layers. The intramural gas is what plain
radiography detects as pneumatosis intestinalis, so this node is where the
mechanism becomes visible at the bedside.
locations:
- preferred_term: wall of small intestine
term:
id: UBERON:0001168
label: wall of small intestine
- preferred_term: colon
term:
id: UBERON:0001155
label: colon
downstream:
- target: Intramural intestinal gas
description: >-
Gas within the bowel wall layers is the radiographic finding this lesion
produces.
- target: Transmural Necrosis and Intestinal Perforation
description: >-
Extension of necrosis through the full wall thickness is what perforates.
- target: Hematochezia
description: >-
Necrosis and sloughing of the mucosal surface is the source of the blood
passed per rectum.
- target: Post-NEC intestinal stricture
description: >-
Where a necrotic segment survives and heals, it heals by fibrosis, which is
why stricture is commonest after medically rather than surgically managed
disease.
- target: Portal venous gas
description: >-
Gas generated in the bowel wall tracks into the draining venules and
reaches the portal venous system, where it is radiographically visible.
evidence:
- reference: PMID:36864828
reference_title: "Imaging for Diagnosis and Assessment of Necrotizing Enterocolitis."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: "Pneumatosis intestinalis refers to gas bubbles/cysts in the mucosal, submucosal, subserosal, or all three bowel wall layers."
explanation: >-
Defines the intramural distribution of gas that this node asserts, layer
by layer.
- reference: PMID:18346531
reference_title: "The neonatal intestinal vasculature: contributing factors to necrotizing enterocolitis."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: "Based on the demonstration of coagulation necrosis, it is clear that intestinal ischemia plays a role in the pathogenesis"
explanation: >-
Attests that the necrosis found in NEC is coagulative, which is the
histological character named in this node.
- name: Transmural Necrosis and Intestinal Perforation
biological_scale: TISSUE
description: >-
Progression of necrosis through the full thickness of the bowel wall,
ending in perforation, enteric spillage and peritonitis. This is the
threshold that converts medical NEC into surgical NEC, and it is the state
that operative intervention is intended to pre-empt or control.
locations:
- preferred_term: wall of small intestine
term:
id: UBERON:0001168
label: wall of small intestine
downstream:
- target: Intestinal perforation
description: >-
Full-thickness necrosis is the immediate cause of the perforation.
- target: Pneumoperitoneum
description: >-
Rupture of the necrotic segment releases intraluminal gas into the
peritoneal cavity, which is the radiographic sign of perforation.
- target: Systemic Inflammatory Response and Sepsis
description: >-
Enteric spillage into the peritoneum accelerates the systemic septic
response.
- target: Short bowel syndrome
description: >-
Resection of the full-thickness-necrotic segment is what removes absorptive
length; residual length is the determinant of intestinal failure.
evidence:
- reference: PMID:38564081
reference_title: "Neonatal Necrotizing Enterocolitis: An Update on Pathophysiology, Treatment, and Prevention."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
resulting in inflammation and necrosis of the small bowel and colon and
potentially leading to sepsis, peritonitis, perforation, and death
explanation: >-
States the progression from necrosis to perforation, peritonitis and
sepsis that this node and its downstream edges represent.
- reference: PMID:27836422
reference_title: "Surgical necrotizing enterocolitis."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: "The primary goals of surgical intervention in NEC are to control enteric spillage and/or resect necrotic intestine while maximizing the length of viable intestine."
explanation: >-
Enteric spillage and resectable necrotic intestine are the operative
problem, which is the clinical correlate of this node.
- name: Systemic Inflammatory Response and Sepsis
biological_scale: ORGANISM
description: >-
Spillover of the mucosal mediator load, together with bacteraemia from
translocated enteric organisms, produces a systemic inflammatory state with
haemodynamic instability, thrombocytopenia and metabolic acidosis. It is
this systemic arm rather than the bowel lesion itself that carries much of
the disease's mortality and its remote organ injury.
downstream:
- target: Neonatal sepsis
description: >-
Enteric organisms reaching the bloodstream give the septic phenotype.
- target: Thrombocytopenia
description: >-
Consumptive thrombocytopenia accompanies the systemic inflammatory state
and is one of the stage II criteria.
- target: Metabolic acidosis
description: >-
Hypoperfusion and the systemic inflammatory state produce the acidosis
that grades stage II and stage III disease.
- target: Cerebral White Matter Injury
description: >-
Circulating inflammatory mediators are the proposed route from the
intestinal lesion to the developing brain.
evidence:
- reference: PMID:413500
reference_title: "Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: PRIMARY_RESULT
snippet: "Enteric organisms were cultured from the blood of four infants dying of NEC."
explanation: >-
Direct human evidence that gut organisms reach the bloodstream in fatal
NEC, which is the bacteraemic component of this node.
- reference: PMID:38564081
reference_title: "Neonatal Necrotizing Enterocolitis: An Update on Pathophysiology, Treatment, and Prevention."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: "potentially leading to sepsis, peritonitis, perforation, and death"
explanation: >-
Names sepsis and death as the systemic endpoints of the intestinal
lesion.
- name: Cerebral White Matter Injury
biological_scale: TISSUE
description: >-
Preterm infants with NEC carry an excess of severe intraventricular
haemorrhage and periventricular leukomalacia, and the excess is larger in
surgical than in medically managed disease. The proposed mechanism is the
circulating proinflammatory mediator load generated by the intestinal
lesion, acting on the vulnerable developing white matter; the dose-response
with disease severity is the main argument that the association is more than
shared prematurity.
notes: >-
Whether this is causal remains open. The meta-analysis cited here says so
explicitly, and confounding by gestational age, illness severity and
nutritional interruption is not fully separable in observational data. No
microglial or astrocytic cell type is bound and no `conforms_to` on
`neuroinflammation_glial_activation` is asserted: the module's central node
is a reactive microglial and astrocytic state, and no source read for this
entry measures glial activation in the brains of infants with NEC. See the
`discussions` entry.
downstream:
- target: Periventricular leukomalacia
description: >-
White matter injury in the periventricular distribution is the imaging
and neuropathological correlate.
- target: Neurodevelopmental delay
description: >-
Periventricular white matter injury is the substrate of the later motor,
cognitive and language deficits.
evidence:
- reference: PMID:38684534
reference_title: "Neurodevelopmental outcomes of preterm with necrotizing enterocolitis: a systematic review and meta-analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
Regarding brain injury, pooled crude ORs indicated an association of NEC
with severe intraventricular haemorrhage (IVH) (OR 1.42, 95% CI 1.06-1.92)
and periventricular leucomalacia (PVL) (OR 2.55, 95% CI 1.76-3.69).
explanation: >-
Quantifies the excess of severe intraventricular haemorrhage and
periventricular leukomalacia in infants with NEC across 33 studies.
- reference: PMID:27836422
reference_title: "Surgical necrotizing enterocolitis."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
directness: INDIRECT
snippet: "claimed to contribute to a mechanism that leads to hemodynamic instability, tissue necrosis, and white matter injury"
explanation: >-
States the proposed mediator route from the intestinal inflammatory
response to white matter injury. INDIRECT and hedged in the source itself
("claimed to"), which is why this node's causal status is recorded as
open.
phenotypes:
- category: Clinical
name: Feeding difficulties
description: >-
Feeding intolerance, usually with raised gastric residuals, is the earliest
and commonest gastrointestinal sign and typically precedes the abdominal and
radiographic findings.
phenotype_term:
preferred_term: Feeding intolerance
term:
id: HP:0011968
label: Feeding difficulties
temporality: ACUTE
diagnostic: true
evidence:
- reference: PMID:27534694
reference_title: "Necrotizing enterocolitis: new insights into pathogenesis and mechanisms."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
The typical neonate with NEC is a premature infant who is thriving, yet
suddenly presents with feeding intolerance, abdominal distension, bloody
stools and signs of sepsis
explanation: >-
Names feeding intolerance as part of the typical presenting picture.
- category: Clinical
name: Abdominal distention
description: >-
Abdominal distension with tenderness and abdominal wall oedema is a
cardinal sign and one of the Bell stage II criteria.
phenotype_term:
preferred_term: Abdominal distension
term:
id: HP:0003270
label: Abdominal distention
temporality: ACUTE
diagnostic: true
evidence:
- reference: PMID:27534694
reference_title: "Necrotizing enterocolitis: new insights into pathogenesis and mechanisms."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
Moderate systemic signs with prominent abdominal distension, abdominal
tenderness and wall oedema
explanation: >-
The Bell stage II row names prominent abdominal distension, tenderness and
wall oedema as defining signs of the medically managed tier.
- category: Clinical
name: Hematochezia
description: >-
Passage of visible blood per rectum, reflecting mucosal necrosis and
sloughing. Occult faecal blood also occurs in NEC and is a softer, less
specific finding; it is deliberately not part of what this row records,
because `HP:0002573 Hematochezia` means blood visible in the stool.
phenotype_term:
preferred_term: Bloody stools
term:
id: HP:0002573
label: Hematochezia
temporality: ACUTE
diagnostic: true
evidence:
- reference: PMID:27534694
reference_title: "Necrotizing enterocolitis: new insights into pathogenesis and mechanisms."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: "suddenly presents with feeding intolerance, abdominal distension, bloody stools and signs of sepsis"
explanation: >-
Names bloody stools as part of the typical presenting picture.
- category: Radiographic
name: Intramural intestinal gas
description: >-
Pneumatosis intestinalis: gas within the bowel wall, considered
pathognomonic for NEC, but present on plain radiography in only about
55-60% of affected infants, so its absence does not exclude the diagnosis.
phenotype_term:
preferred_term: Pneumatosis intestinalis
term:
id: HP:6000377
label: Intramural intestinal gas
diagnostic: true
frequency: COMMON
evidence:
- reference: PMID:36864828
reference_title: "Imaging for Diagnosis and Assessment of Necrotizing Enterocolitis."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
More specific radiographic findings, which have been considered
pathognomonic for NEC, include pneumatosis intestinalis and the detection
of radiolucent gas in the portal venous system
explanation: >-
Establishes pneumatosis intestinalis as the specific, near-pathognomonic
radiographic finding of NEC.
- reference: PMID:36864828
reference_title: "Imaging for Diagnosis and Assessment of Necrotizing Enterocolitis."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: "pneumatosis is seen only in 55-60% of all infants with NEC"
explanation: >-
Quantifies the sensitivity limitation recorded in this phenotype's
description, supporting the COMMON rather than universal frequency band.
- category: Radiographic
name: Portal venous gas
description: >-
Radiolucent gas in the portal venous system, seen as branching lucency over
the liver. It is the second finding considered near-pathognomonic for NEC,
and it arises from the same intramural gas: gas generated in the bowel wall
tracks into the draining venules.
phenotype_term:
preferred_term: Hepatic portal venous gas
diagnostic: true
evidence:
- reference: PMID:36864828
reference_title: "Imaging for Diagnosis and Assessment of Necrotizing Enterocolitis."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
Some of these collected gases gradually find their way into the local
venules that drain into the portal venous system and can be seen as
branching radiolucency against the relatively opaque background of the
liver
explanation: >-
States both the route from intramural gas to the portal venous system and
the radiographic appearance this phenotype records.
- reference: PMID:36864828
reference_title: "Imaging for Diagnosis and Assessment of Necrotizing Enterocolitis."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
More specific radiographic findings, which have been considered
pathognomonic for NEC, include pneumatosis intestinalis and the detection
of radiolucent gas in the portal venous system
explanation: >-
Names portal venous gas alongside pneumatosis as the specific,
near-pathognomonic radiographic findings of NEC.
notes: >-
Left unbound. HPO has no portal-venous-gas class. Searches run against OLS
HP: `l~portal venous gas` and `l~hepatoportal` each return nothing;
`l~portal` returns eleven terms, all of them portal vein or portal tract
morphology and haemodynamics (hypertension, thrombosis, fibrosis,
hypoplasia, sclerosis, absence, inflammation, velocity, venule thickening),
none a gas finding; `l~gas` is truncated at the OLS 50-result page limit and
so cannot be read as a negative. Positive controls on the same adapter in
the same session: `l~intramural` returns `HP:6000377 Intramural intestinal
gas` and `l~Hematochezia` returns `HP:0002573`, so the adapter was live and
the absence is HPO's, not the lookup's. `preferred_term` carries the concept
rather than asserting a wrong binding.
- category: Radiographic
name: Pneumoperitoneum
description: >-
Free gas in the peritoneal cavity, released when necrotic bowel ruptures.
Radiographic pneumoperitoneum is the only absolute indication for operation
in NEC, but it is insensitive: fewer than half of infants found to have
perforation or necrosis at laparotomy show it.
phenotype_term:
preferred_term: Pneumoperitoneum
diagnostic: true
severity: SEVERE
evidence:
- reference: PMID:36864828
reference_title: "Imaging for Diagnosis and Assessment of Necrotizing Enterocolitis."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
In severe cases, the necrotic bowel ruptures to release the intraluminal
air into the peritoneal cavity.
explanation: >-
States the mechanism by which the free peritoneal gas of this phenotype
arises, which is the causal edge drawn from the transmural-necrosis node.
- reference: PMID:27836422
reference_title: "Surgical necrotizing enterocolitis."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: "Evidence of pneumoperitoneum on plain radiography is the only absolute criteria for operative intervention."
explanation: >-
Establishes the operative significance of the finding recorded in this
phenotype's description.
- reference: PMID:27836422
reference_title: "Surgical necrotizing enterocolitis."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
Pneumoperitoneum is present in less than half of all infants with
intestinal perforation or necrosis at the time of operative exploration,
demonstrating that it is a relatively insensitive marker of infants with
surgical NEC.
explanation: >-
Quantifies the insensitivity recorded in this phenotype's description.
notes: >-
Left unbound. HPO has no pneumoperitoneum or free-intraperitoneal-gas class.
Searches run against OLS HP: `l~pneumoperitoneum`, `l~pneumatosis`,
`l~free air`, `l~intraperitoneal` and `l~peritoneal gas` each return
nothing; `l~peritoneal` returns nine terms (peritonitis, meconium
peritonitis, abnormal peritoneum morphology, peritoneal abscess, peritoneal
mass, three peritoneal neoplasms, positive peritoneal fluid culture) and
none is a gas finding; `l~air` returns twenty-seven terms, every one
pulmonary or airway. Positive controls on the same adapter in the same
session: `l~intramural` returns `HP:6000377 Intramural intestinal gas` and
`l~Hematochezia` returns `HP:0002573`. Note HPO does hold the sibling
finding as `HP:6000377`, so the gap is specific to free and portal gas
rather than to radiographic gas findings generally.
- category: Clinical
name: Intestinal perforation
description: >-
Full-thickness bowel necrosis with perforation. Radiographic
pneumoperitoneum is the only absolute indication for operation in NEC,
although it is present in fewer than half of infants found to have
perforation or necrosis at laparotomy.
phenotype_term:
preferred_term: Intestinal perforation
term:
id: HP:0031368
label: Intestinal perforation
temporality: ACUTE
severity: SEVERE
diagnostic: true
evidence:
- reference: PMID:38564081
reference_title: "Neonatal Necrotizing Enterocolitis: An Update on Pathophysiology, Treatment, and Prevention."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: "potentially leading to sepsis, peritonitis, perforation, and death"
explanation: >-
Names perforation among the outcomes of established NEC.
- reference: PMID:27836422
reference_title: "Surgical necrotizing enterocolitis."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
Pneumoperitoneum is present in less than half of all infants with
intestinal perforation or necrosis at the time of operative exploration,
demonstrating that it is a relatively insensitive marker of infants with
surgical NEC.
explanation: >-
Quantifies the insensitivity of pneumoperitoneum recorded in this
phenotype's description: perforation is present more often than the
radiographic sign that is its only absolute indication for operation.
- category: Clinical
name: Neonatal sepsis
description: >-
Systemic inflammatory response with culture-positive bacteraemia from
translocated enteric organisms; the septic signs are often what brings the
infant to attention.
phenotype_term:
preferred_term: Neonatal sepsis
term:
id: HP:0040187
label: Neonatal sepsis
temporality: ACUTE
severity: SEVERE
evidence:
- reference: PMID:413500
reference_title: "Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: PRIMARY_RESULT
snippet: "Enteric organisms were cultured from the blood of four infants dying of NEC."
explanation: >-
Culture-confirmed enteric bacteraemia in infants dying of NEC.
- reference: PMID:27534694
reference_title: "Necrotizing enterocolitis: new insights into pathogenesis and mechanisms."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
signs of sepsis (that is, changes in heart rate, respiratory rate,
temperature and blood pressure)
explanation: >-
Names the septic signs that form part of the presenting picture and
specifies what they consist of.
- category: Laboratory
name: Thrombocytopenia
description: >-
Falling platelet count accompanies the systemic inflammatory response and is
one of the Bell stage II laboratory criteria.
phenotype_term:
preferred_term: Thrombocytopenia
term:
id: HP:0001873
label: Thrombocytopenia
temporality: ACUTE
diagnostic: true
evidence:
- reference: PMID:27534694
reference_title: "Necrotizing enterocolitis: new insights into pathogenesis and mechanisms."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
Moderate NEC | Moderate systemic signs with prominent abdominal
distension, abdominal tenderness and wall oedema Thrombocytopenia and
metabolic acidosis
explanation: >-
The Bell staging table lists thrombocytopenia among the laboratory
criteria that define moderate, medically managed disease.
- category: Laboratory
name: Metabolic acidosis
description: >-
Metabolic acidosis reflects tissue hypoperfusion; it is a stage II criterion
and becomes severe, with shock, at stage III.
phenotype_term:
preferred_term: Metabolic acidosis
term:
id: HP:0001942
label: Metabolic acidosis
temporality: ACUTE
diagnostic: true
evidence:
- reference: PMID:27534694
reference_title: "Necrotizing enterocolitis: new insights into pathogenesis and mechanisms."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: "Severe metabolic acidosis and shock."
explanation: >-
The Bell stage III row names severe metabolic acidosis with shock as a
defining feature of advanced disease.
- category: Gastrointestinal
name: Post-NEC intestinal stricture
description: >-
Fibrotic narrowing of healed bowel is the commonest late gastrointestinal
complication, reported in roughly 12-35% of survivors, more frequent after
medical than surgical management, and affecting the colon in up to 80% of
cases.
phenotype_term:
preferred_term: Post-NEC colonic stricture
term:
id: HP:0012851
label: Colonic stenosis
temporality: CHRONIC
frequency: COMMON
evidence:
- reference: PMID:30864508
reference_title: "Necrotizing Enterocolitis: Long Term Complications."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
Common complications of NEC include neurodevelopmental delay, failure to
thrive, gastrointestinal problems including strictures and adhesions,
cholestasis, short bowel syndrome with or without intestinal failure that
can be difficult to manage.
explanation: >-
Names strictures among the common long-term complications of NEC.
- reference: PMID:27534694
reference_title: "Necrotizing enterocolitis: new insights into pathogenesis and mechanisms."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: "Intestinal strictures | 12-35%"
explanation: >-
The review's complications table gives the incidence range quoted in this
phenotype's description.
- reference: PMID:27534694
reference_title: "Necrotizing enterocolitis: new insights into pathogenesis and mechanisms."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
Most frequent in patients managed medically Affects colon in up to 80%
explanation: >-
The same complications-table row gives both the medical-versus-surgical
gradient and the colonic predominance, which is why the colon is the site
bound here.
notes: >-
Bound to `HP:0012851 Colonic stenosis` because the colon is the site the
cited review puts up to 80% of post-NEC strictures in. HPO has no generic
intestinal-stricture or intestinal-stenosis class to bind instead. Searches
run against OLS HP: `l~stricture` returns nine terms, all site-specific
(anorectal, urethral, esophageal, `HP:0020002 Ileal stricture`, vaginal,
ureteric), which is the whole of HPO's "stricture" vocabulary and contains
no generic parent; `l~stenosis` returns 50 terms including `HP:0012851
Colonic stenosis`; `l~intestinal stenosis` returns only `HP:0012848 Small
intestinal stenosis`. HPO therefore names this concept by site and by the
word *stenosis*, not *stricture*, which is why a search on *stricture*
alone reads as an absence. `HP:0012848` would carry the non-colonic
minority, but no source read for this entry names or quantifies the
small-bowel share, so a second row is not asserted on the strength of the
"up to 80%" complement alone. Note that an `l~` search returning exactly 50
results is truncated at the OLS page limit, so a negative drawn from one is
not a negative: `l~gas` returns 50 and misses `HP:6000377`, which
`l~intramural` returns directly.
- category: Gastrointestinal
name: Short bowel syndrome
description: >-
Extensive resection of necrotic bowel, or a long segment lost to the disease
itself, leaves insufficient absorptive length, reported in roughly 20-35% of
survivors and the main route to long-term parenteral nutrition dependence.
phenotype_term:
preferred_term: Short bowel syndrome
temporality: CHRONIC
frequency: COMMON
sequelae:
- target: Cholestasis
description: >-
Short bowel syndrome is what makes parenteral nutrition dependence
prolonged, and prolonged dependence is what produces the cholestasis.
- target: Failure to thrive
description: >-
Insufficient absorptive length is the route to growth failure, which the
cited review reports is most severe in post-NEC short bowel syndrome.
evidence:
- reference: PMID:30864508
reference_title: "Necrotizing Enterocolitis: Long Term Complications."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
short bowel syndrome with or without intestinal failure that can be
difficult to manage
explanation: >-
Names short bowel syndrome with or without intestinal failure as a
long-term complication.
- reference: PMID:27534694
reference_title: "Necrotizing enterocolitis: new insights into pathogenesis and mechanisms."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: "Short Bowel Syndrome | 20-35%"
explanation: >-
The review's complications table gives the incidence range quoted in this
phenotype's description.
notes: >-
Left unbound. HPO has no class for acquired short bowel syndrome. Searches
against OLS HP: `short bowel` returns only `HP:0030889 Congenital shortened
small intestine` (synonym "Short bowel"), which is congenital and so the
wrong concept for a post-resection state; `intestinal failure` returns only
agenesis terms; `malabsorption` returns `HP:0002024 Malabsorption`, which is
a consequence rather than this entity. `HP:0033994 Dependency on parenteral
nutrition` names the management consequence and is also not this entity.
`preferred_term` carries the concept rather than asserting a wrong binding.
- category: Gastrointestinal
name: Cholestasis
description: >-
Cholestasis in NEC survivors is driven by prolonged parenteral nutrition
dependence and by the loss of enteral feeding during and after the acute
illness.
phenotype_term:
preferred_term: Cholestasis
term:
id: HP:0001396
label: Cholestasis
temporality: CHRONIC
evidence:
- reference: PMID:30864508
reference_title: "Necrotizing Enterocolitis: Long Term Complications."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
gastrointestinal problems including strictures and adhesions, cholestasis,
short bowel syndrome with or without intestinal failure
explanation: >-
Names cholestasis among the long-term complications of NEC.
- category: Growth
name: Failure to thrive
description: >-
Growth failure after NEC, most marked in infants left with short bowel
syndrome.
phenotype_term:
preferred_term: Failure to thrive
term:
id: HP:0001508
label: Failure to thrive
temporality: CHRONIC
evidence:
- reference: PMID:30864508
reference_title: "Necrotizing Enterocolitis: Long Term Complications."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: "Common complications of NEC include neurodevelopmental delay, failure to thrive"
explanation: >-
Names failure to thrive among the common long-term complications.
- category: Neurologic
name: Periventricular leukomalacia
description: >-
White matter injury in the periventricular distribution is over-represented
in infants with NEC, with a pooled crude odds ratio of about 2.6.
phenotype_term:
preferred_term: Periventricular leukomalacia
term:
id: HP:0006970
label: Periventricular leukomalacia
evidence:
- reference: PMID:38684534
reference_title: "Neurodevelopmental outcomes of preterm with necrotizing enterocolitis: a systematic review and meta-analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: "periventricular leucomalacia (PVL) (OR 2.55, 95% CI 1.76-3.69)"
explanation: >-
Gives the pooled effect estimate quoted in this phenotype's description.
- category: Neurologic
name: Neurodevelopmental delay
description: >-
Motor, cognitive and language developmental delay is the dominant long-term
morbidity of NEC survivors, with an adjusted odds ratio of about 1.9 against
preterm infants without NEC, and a further excess in infants who required
surgery.
phenotype_term:
preferred_term: Neurodevelopmental impairment
term:
id: HP:0012758
label: Neurodevelopmental delay
temporality: CHRONIC
frequency: COMMON
evidence:
- reference: PMID:38684534
reference_title: "Neurodevelopmental outcomes of preterm with necrotizing enterocolitis: a systematic review and meta-analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
Meta-analysis of unadjusted and adjusted ORs demonstrated a significant
association between NEC and increased odds of NDI (OR 2.15, 95% CI
1.9-2.44; aOR 1.89, 95% CI 1.46-2.46).
explanation: >-
Gives both the unadjusted and adjusted pooled effect estimates quoted in
this phenotype's description, across 60,346 infants.
- reference: PMID:38684534
reference_title: "Neurodevelopmental outcomes of preterm with necrotizing enterocolitis: a systematic review and meta-analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
When compared with conservatively treated NEC, surgical NEC potentially
carries a higher risk of NDI (OR 1.78, 95% CI 1.09-2.93)
explanation: >-
Supports the surgical-versus-medical gradient recorded in this
phenotype's description, which is the severity dose-response argument
for the association being more than shared prematurity.
histopathology:
- name: Coagulative necrosis of the bowel wall
description: >-
Coagulative necrosis is the characteristic histology of resected NEC bowel,
and its ischemic character is the main histological argument that
hypoperfusion sits in the causal chain rather than merely following
inflammation.
finding_term:
preferred_term: coagulative necrosis
term:
id: NCIT:C39608
label: Coagulative Necrosis
diagnostic: true
evidence:
- reference: PMID:18346531
reference_title: "The neonatal intestinal vasculature: contributing factors to necrotizing enterocolitis."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: "Based on the demonstration of coagulation necrosis, it is clear that intestinal ischemia plays a role in the pathogenesis of necrotizing enterocolitis (NEC)."
explanation: >-
Attests coagulation necrosis as a demonstrated finding in NEC and draws
the ischemic inference this finding's description records.
genetic:
- name: SIGIRR
gene_term:
preferred_term: SIGIRR
term:
id: hgnc:30575
label: SIGIRR
relationship_type: SUSCEPTIBILITY
variant_origin: GERMLINE
association: >-
Rare loss-of-function SIGIRR variants are reported in premature infants with
stage II and worse NEC. SIGIRR is a negative regulator of TLR4 signalling
enriched in intestinal epithelium, so loss of function is mechanistically
coherent with the dominant arm of this entry: it lowers the threshold at
which a given luminal lipopolysaccharide load activates epithelial TLR4.
This is a susceptibility claim, not a causal one - NEC is not Mendelian and
no gene is necessary or sufficient for it.
evidence:
- reference: PMID:25963006
reference_title: "SIGIRR genetic variants in premature infants with necrotizing enterocolitis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: PRIMARY_RESULT
directness: DIRECT
snippet: >-
Additionally, Sanger sequencing identified missense, stop, or splice
region SIGIRR variants in 10 of 17 premature infants with stage II+ NEC.
explanation: >-
The human genetic observation this susceptibility record rests on:
SIGIRR variants sequenced directly in a NEC cohort, staged.
- reference: PMID:25963006
reference_title: "SIGIRR genetic variants in premature infants with necrotizing enterocolitis."
supports: SUPPORT
evidence_source: IN_VITRO
quote_role: PRIMARY_RESULT
directness: DIRECT
snippet: >-
The genetic variants identified in the infant with NEC resulted in loss of
SIGIRR function and exaggerated inflammation in response to
lipopolysaccharide.
explanation: >-
Functional corroboration in cells that the variants are loss-of-function
and that the consequence is an exaggerated lipopolysaccharide response,
which is the mechanism this record asserts rather than merely a variant
list.
notes: >-
`gene_disease_validity` is deliberately absent: no external body has
classified the SIGIRR-NEC pair, and a tier is copied from a source rather
than assigned here. The supporting cohort is 17 sequenced infants with no
matched preterm control group reported, so "10 of 17" is a variant frequency
among cases and not an association estimate - it cannot be read as an effect
size, and the same variants may well be carried by preterm infants who never
develop NEC. No causal `genetic:` record is curated for any NEC gene for
that reason.
prevalence:
- population: >-
US infants 23-29 weeks' gestation and birth weight under 1,500 g,
Pediatrix Medical Group 2015-2019
measure_type: PERIOD_PREVALENCE
prevalence_class: ABOVE_1_IN_1000
rate_per_100000: 3400.0
notes: >-
1,150 of 34,032 infants (3.4%) diagnosed with medical NEC in a contemporary
US multicentre cohort of very preterm, very low birth weight infants. Not a
general-population rate: the denominator is the at-risk preterm population,
which is the only denominator in which NEC occurrence is meaningful.
evidence:
- reference: PMID:35554890
reference_title: "Necrotizing Enterocolitis in Very Low Birth Weight Neonates: A Natural History Study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: "Among 34,032 patients in the contemporary cohort, 1,150 (3.4%) were diagnosed with medical NEC and 543 (1.6%) were diagnosed with surgical NEC."
explanation: >-
Gives the numerator, denominator and percentage for medical NEC in the
cohort named in this record's population.
- population: >-
US infants 23-29 weeks' gestation and birth weight under 1,500 g,
Pediatrix Medical Group 2015-2019, surgical NEC
measure_type: PERIOD_PREVALENCE
prevalence_class: ABOVE_1_IN_1000
rate_per_100000: 1600.0
notes: >-
543 of 34,032 infants (1.6%) diagnosed with surgical NEC in the same cohort.
Recorded separately from medical NEC because the two tiers differ in onset
pattern, risk factors and mortality rather than only in severity.
evidence:
- reference: PMID:35554890
reference_title: "Necrotizing Enterocolitis in Very Low Birth Weight Neonates: A Natural History Study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: "543 (1.6%) were diagnosed with surgical NEC"
explanation: >-
Gives the surgical NEC numerator and percentage in the cohort named in
this record's population.
environmental:
- name: Preterm formula feeding in the absence of human milk
description: >-
Feeding preterm infants formula rather than human milk raises NEC risk
roughly twofold in randomized comparisons. Whether this reflects an
injurious constituent of formula or the absence of protective constituents
of human milk is not settled; the pooled effect is the same either way.
causal_role: RISK_FACTOR
exposure_term:
preferred_term: preterm formula feeding
notes: >-
Left unbound. ECTO has no infant-formula or human-milk feeding exposure
class. Searches run against the local ECTO build: `runoak -i
sqlite:obo:ecto search "l~formula"` returns no ECTO term at all;
`l~human milk` returns only FOODON classes (`FOODON:00001958`,
`FOODON:03303918`); `l~breast` and `l~infant` each return nothing in ECTO;
`l~milk` returns thirteen ECTO ingestion classes of which the closest,
`ECTO:0070204 exposure to cow milk (liquid) via ingestion`, names a
beverage rather than a preterm formula and is not bound because it would
assert a different exposure.
influences_mechanisms:
- target: Abnormal Microbial Colonization of the Preterm Gut
environmental_effect: PREDISPOSES
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
description: >-
Formula lacks the human milk oligosaccharides that shape Bifidobacterium
colonization; low delivery of one such oligosaccharide, DSLNT, tracks with
a reduced transition into Bifidobacterium-dominated preterm gut
communities and with NEC. The intermediate steps between oligosaccharide
supply and community structure are not established, so the link is
indirect.
evidence:
- reference: PMID:33328245
reference_title: "Human milk oligosaccharide DSLNT and gut microbiome in preterm infants predicts necrotising enterocolitis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
Longitudinal development of the microbiome was also impacted by low MOM
DSLNT associated with reduced transition into preterm gut community
types dominated by Bifidobacterium spp
explanation: >-
Links low delivery of a human milk oligosaccharide to the failure of the
Bifidobacterium-dominated community transition, which is the
colonization mechanism this link asserts.
evidence:
- reference: PMID:32384652
reference_title: "The Impact of Human Milk on Necrotizing Enterocolitis: A Systematic Review and Meta-Analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: "RCTs meta-analysis indicates a risk reduction of NEC using human milk respect to formula: Relative risk (RR) = 0.62 (0.42-0.93)."
explanation: >-
Pooled randomized evidence quantifying the human-milk-versus-formula
contrast that defines this exposure, in the protective direction.
- reference: PMID:27534694
reference_title: "Necrotizing enterocolitis: new insights into pathogenesis and mechanisms."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
Whether the development of NEC in association with formula feeding
represents the presence of an injurious component in infant formula, or
the deficiency of a protective agent only present in breast milk remains
to be determined
explanation: >-
Supports the unresolved-mechanism caveat recorded in this exposure's
description, in the review's own words.
- name: Early broad-spectrum antibiotic exposure
description: >-
Antibiotic exposure in the first days and weeks of life reshapes the
colonizing community of the preterm gut and is reported as a risk factor for
subsequent NEC. It is also the treatment given for suspected sepsis, so the
exposure is near-universal in the at-risk population and hard to separate
from the illness that prompts it.
causal_role: RISK_FACTOR
exposure_term:
preferred_term: exposure to antibacterial drug
term:
id: ECTO:9001757
label: exposure to antibacterial drug
influences_mechanisms:
- target: Abnormal Microbial Colonization of the Preterm Gut
environmental_effect: PREDISPOSES
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
description: >-
Broad-spectrum antibiotics deplete the colonizing community, and the
resulting delay and distortion of colonization is the proposed route to
the abnormal community structure that precedes NEC.
evidence:
- reference: PMID:27534694
reference_title: "Necrotizing enterocolitis: new insights into pathogenesis and mechanisms."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
directness: INDIRECT
snippet: >-
A late onset of NEC in the most premature infants might be related to
delayed microbial colonization of the gut and establishment of virulent
microbial agents, in part owing to the use of broad-spectrum antibiotics
and prolonged hospital stay
explanation: >-
Attributes delayed and distorted colonization in part to
broad-spectrum antibiotic use, which is the mechanism this link
asserts. Hedged in the source ("might be related to"), hence INDIRECT.
evidence:
- reference: PMID:38564081
reference_title: "Neonatal Necrotizing Enterocolitis: An Update on Pathophysiology, Treatment, and Prevention."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
This review also highlights the effect of early antibiotic exposure,
infections, proton pump inhibitors (PPIs), and H2 receptor antagonists on
the microbiota and how these risk factors can increase the chances of NEC.
explanation: >-
Names early antibiotic exposure as a risk factor acting on the microbiota
to increase NEC risk.
- name: Packed red blood cell transfusion in the anemic preterm infant
description: >-
Transfusion-associated NEC: clinical studies link NEC onset to an antecedent
red blood cell transfusion. Whether transfusion or the anemia that prompts it
is the operative exposure is contested, and the two are hard to separate
because the sickest and most anemic infants are the ones transfused. A murine
model resolves the pair into a two-hit sequence in which anemia primes
intestinal macrophages and transfusion then activates them through TLR4.
causal_role: RISK_FACTOR
exposure_term:
preferred_term: exposure to packed red blood cell transfusion
term:
id: ECTO:2000058
label: exposure to blood transfusion
notes: >-
Transfusion sits on both sides of this entry: it is a putative risk exposure
at onset and a supportive treatment for the anemia and coagulopathy of
established disease. The two are not in conflict - different timing,
different context - and neither should be read as cancelling the other. The
human association is recorded as contested rather than established, so the
mechanism link is PREDISPOSES and not TRIGGERS, even though the model
demonstrates triggering directly.
influences_mechanisms:
- target: Mucosal Proinflammatory Cytokine Amplification
environmental_effect: PREDISPOSES
causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
description: >-
The intermediates are named rather than assumed: the anemic intestine is
infiltrated by inflammatory macrophages, and red cell degradation products
delivered by transfusion activate those macrophages through TLR4. This is a
third TLR4-dependent input into the same mucosal amplification node the
epithelial and endothelial arms converge on, and it is why chelating the
degradation products with haptoglobin is protective in the model.
evidence:
- reference: PMID:31375667
reference_title: "A murine neonatal model of necrotizing enterocolitis caused by anemia and red blood cell transfusions."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
quote_role: PRIMARY_RESULT
directness: INDIRECT
snippet: >-
The anemic intestine is infiltrated by inflammatory macrophages, which
are activated in situ by RBC transfusions via a Toll-like receptor
(TLR)-4-mediated mechanism and cause bowel injury.
explanation: >-
Names the macrophage and TLR4 intermediates this link asserts, and the
bowel injury they cause. INDIRECT because the mechanism is demonstrated
in neonatal mice and carried across to the human node by inference.
- reference: PMID:31375667
reference_title: "A murine neonatal model of necrotizing enterocolitis caused by anemia and red blood cell transfusions."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
quote_role: PRIMARY_RESULT
directness: INDIRECT
snippet: >-
Chelation of RBC degradation products with haptoglobin, absence of TLR4,
macrophage depletion, and inhibition of macrophage activation is
protective.
explanation: >-
Four independent interruptions of the proposed chain are each protective,
which is what establishes the macrophage-TLR4 route as required in the
model rather than merely present alongside the injury.
evidence:
- reference: PMID:31375667
reference_title: "A murine neonatal model of necrotizing enterocolitis caused by anemia and red blood cell transfusions."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: BACKGROUND
directness: DIRECT
snippet: >-
Clinical studies have linked NEC with antecedent red blood cell (RBC)
transfusions, but the underlying mechanisms are unclear.
explanation: >-
States the human clinical association that makes this an exposure worth
recording, and its unsettled mechanism. Graded HUMAN_CLINICAL for the
clinical claim the sentence makes, with quote_role BACKGROUND because the
citing paper is a murine study restating it.
- reference: PMID:31375667
reference_title: "A murine neonatal model of necrotizing enterocolitis caused by anemia and red blood cell transfusions."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
quote_role: PRIMARY_RESULT
directness: INDIRECT
snippet: >-
Intestinal injury worsens with increasing severity and the duration of
anemia prior to transfusion, indicating a need for the re-evaluation of
current transfusion guidelines for premature infants.
explanation: >-
The dose-response on anemia rather than on transfusion volume is the
model's own argument that anemia carries much of the causal weight, which
is the contested point recorded in this exposure's description.
- name: Proton pump inhibitor exposure
description: >-
Acid suppression with a proton pump inhibitor raises gastric pH and is
reported as a NEC risk factor acting through the colonizing community. As
with antibiotics, the exposure is common in the at-risk population and is
given for reflux and feeding problems that overlap with early NEC signs.
causal_role: RISK_FACTOR
exposure_term:
preferred_term: exposure to proton pump inhibitors
term:
id: ECTO:2000019
label: exposure to proton pump inhibitors
notes: >-
Curated as two entries, one per drug class, because ECTO has no class
covering acid suppression as a whole: `l~antiulcer`, `l~gastric acid` and
`l~acid suppress` against the local ECTO build each return nothing, while
`l~proton pump` returns `ECTO:2000019` and `l~histamine` returns
`ECTO:9001771 exposure to histamine antagonist`. A single entry would have
had to bind one class and silently cover the other. The two entries share
their supporting sentence because the cited review names both classes in one
breath and separates neither.
influences_mechanisms:
- target: Abnormal Microbial Colonization of the Preterm Gut
environmental_effect: PREDISPOSES
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
description: >-
Loss of the gastric acid barrier is the proposed route by which acid
suppression reshapes the colonizing community of the preterm gut. The steps
between raised gastric pH and the community structure that precedes NEC are
not established, so the link is indirect.
evidence:
- reference: PMID:38564081
reference_title: "Neonatal Necrotizing Enterocolitis: An Update on Pathophysiology, Treatment, and Prevention."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
directness: INDIRECT
snippet: >-
This review also highlights the effect of early antibiotic exposure,
infections, proton pump inhibitors (PPIs), and H2 receptor antagonists on
the microbiota and how these risk factors can increase the chances of
NEC.
explanation: >-
Locates the effect of proton pump inhibitors on the microbiota, which is
the node this link names, and then on NEC risk. INDIRECT because the
review asserts the microbiota route without measuring the intermediate
steps.
evidence:
- reference: PMID:38564081
reference_title: "Neonatal Necrotizing Enterocolitis: An Update on Pathophysiology, Treatment, and Prevention."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
This review also highlights the effect of early antibiotic exposure,
infections, proton pump inhibitors (PPIs), and H2 receptor antagonists on
the microbiota and how these risk factors can increase the chances of NEC.
explanation: >-
Names proton pump inhibitors among the risk factors that act on the
microbiota to increase NEC risk.
- name: Histamine H2 receptor antagonist exposure
description: >-
Acid suppression with an H2 receptor antagonist is reported as a NEC risk
factor on the same account as proton pump inhibitors: raised gastric pH
alters the colonizing community of the preterm gut.
causal_role: RISK_FACTOR
exposure_term:
preferred_term: exposure to histamine H2 receptor antagonist
term:
id: ECTO:9001771
label: exposure to histamine antagonist
notes: >-
The binding is broader than the exposure. ECTO's `exposure to histamine
antagonist` spans H1 antagonists as well, and searches against the local ECTO
build return no H2-specific class: `l~histamine` returns only
`ECTO:9000248 exposure to histamine` and `ECTO:9001771`, and `l~ranitidine`
returns the agent-level `ECTO:9000887 exposure to ranitidine`, which names
one drug rather than the class the source describes. `preferred_term` carries
the H2 specificity. See the sibling proton pump inhibitor entry for why the
two classes are curated separately.
influences_mechanisms:
- target: Abnormal Microbial Colonization of the Preterm Gut
environmental_effect: PREDISPOSES
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
description: >-
H2 blockade raises gastric pH and is proposed to reshape the colonizing
community of the preterm gut by the same route as proton pump inhibition,
with the intermediate steps equally unestablished.
evidence:
- reference: PMID:38564081
reference_title: "Neonatal Necrotizing Enterocolitis: An Update on Pathophysiology, Treatment, and Prevention."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
directness: INDIRECT
snippet: >-
This review also highlights the effect of early antibiotic exposure,
infections, proton pump inhibitors (PPIs), and H2 receptor antagonists on
the microbiota and how these risk factors can increase the chances of
NEC.
explanation: >-
Locates the effect of H2 receptor antagonists on the microbiota, which is
the node this link names. INDIRECT because the review asserts the
microbiota route without measuring the intermediate steps.
evidence:
- reference: PMID:38564081
reference_title: "Neonatal Necrotizing Enterocolitis: An Update on Pathophysiology, Treatment, and Prevention."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
This review also highlights the effect of early antibiotic exposure,
infections, proton pump inhibitors (PPIs), and H2 receptor antagonists on
the microbiota and how these risk factors can increase the chances of NEC.
explanation: >-
Names H2 receptor antagonists among the risk factors that act on the
microbiota to increase NEC risk.
treatments:
- name: Human Milk Feeding
description: >-
Feeding human milk rather than preterm formula is the best-established
preventive intervention. Mother's own milk is preferred; where it is
unavailable, pasteurised donor human milk roughly halves NEC risk against
formula in trials at low risk of bias.
treatment_term:
preferred_term: human milk feeding
term:
id: NCIT:C15447
label: Dietary Intervention
therapeutic_modality: BEHAVIORAL
role: preventive
target_mechanisms:
- target: Epithelial TLR4 Hyperactivation by Luminal Lipopolysaccharide
description: >-
Human milk inhibits epithelial TLR4 signalling through EGF-dependent
activation of the epidermal growth factor receptor, which is the
mechanistic account of its protective effect in murine NEC.
evidence:
- reference: PMID:25899687
reference_title: "Breast milk protects against the development of necrotizing enterocolitis through inhibition of Toll-like receptor 4 in the intestinal epithelium via activation of the epidermal growth factor receptor."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
directness: DIRECT
snippet: >-
Breast milk protected against NEC and reduced TLR4 signaling in
wild-type neonatal mice, but not in mice lacking the epidermal growth
factor receptor (EGFR), whereas selective removal of EGF from breast
milk reduced its protective properties, indicating that breast milk
inhibits NEC and attenuates TLR4 signaling via EGF/EGFR activation.
explanation: >-
Receptor-knockout and ligand-depletion arms together establish that the
protection acts on TLR4 signalling through EGFR, which is the target
this link names.
evidence:
- reference: PMID:39239939
reference_title: "Donor human milk for preventing necrotising enterocolitis in very preterm or very low-birthweight infants."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: "donor human milk reduces the risk of NEC (RR 0.39, 95% CI 0.22 to 0.70"
explanation: >-
Cochrane meta-analysis restricted to trials at low risk of bias across all
domains gives the donor-milk effect estimate quoted in this treatment's
description.
- reference: PMID:32384652
reference_title: "The Impact of Human Milk on Necrotizing Enterocolitis: A Systematic Review and Meta-Analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: "RCTs meta-analysis indicates a risk reduction of NEC using human milk respect to formula: Relative risk (RR) = 0.62 (0.42-0.93)."
explanation: >-
Independent pooled randomized estimate of the human-milk protective
effect.
- name: Probiotic Supplementation
description: >-
Supplemental probiotics, most often Bifidobacterium and Lactobacillus
preparations, reduce NEC risk in very preterm and very low birth weight
infants, although the certainty of the evidence is low and the benefit is
not demonstrated in the extremely preterm subgroup where the risk is
highest.
treatment_term:
preferred_term: probiotic supplementation
term:
id: NCIT:C15447
label: Dietary Intervention
therapeutic_modality: OTHER
role: preventive
target_mechanisms:
- target: Abnormal Microbial Colonization of the Preterm Gut
description: >-
Probiotics are given in order to modify the colonizing community, which is
the node they are intended to act on.
evidence:
- reference: PMID:37493095
reference_title: "Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
Dietary supplementation with probiotics to modulate the intestinal
microbiome has been proposed as a strategy to reduce the risk of NEC
explanation: >-
States the intended target of the intervention. INDIRECT because the
Cochrane review measures the clinical outcome rather than the
community-structure change the link asserts.
evidence:
- reference: PMID:37493095
reference_title: "Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: "Probiotics may reduce the risk of NEC (RR 0.54, 95% CI 0.46 to 0.65"
explanation: >-
Cochrane pooled estimate over 57 trials and 10,918 infants, graded low
certainty by the review's own GRADE assessment.
- reference: PMID:37493095
reference_title: "Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants."
supports: REFUTE
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
In this population, probiotics may have little or no effect on NEC (RR
0.92, 95% CI 0.69 to 1.22
explanation: >-
In extremely preterm and extremely low birth weight infants the same
review finds no effect, which contradicts a general claim of benefit in
the highest-risk subgroup and is the caveat recorded in this treatment's
description.
notes: >-
`therapeutic_modality: OTHER` rather than the `BEHAVIORAL` that
`NCIT:C15447 Dietary Intervention` would suggest mechanically. A probiotic
is a dose of live organisms given to alter the colonizing community, not a
change in diet pattern, and none of the platform values names a live
biotherapeutic. This is the same reason the mechanical backfill table
excludes nutritional-supplementation terms.
- name: Standardized Feeding Regimen
description: >-
Unit-level standardized feeding guidelines, with preset thresholds for
managing feeding intolerance, have reduced NEC incidence and severity where
implemented. What standardization does not require is slow feed advancement:
pooled randomized evidence shows that advancing enteral volumes slowly
(daily increments up to 24 mL/kg) rather than faster does not reduce NEC, and
may slightly increase invasive infection. The benefit appears to lie in
consistency of practice rather than in caution about volume.
treatment_term:
preferred_term: standardized enteral feeding regimen
term:
id: NCIT:C15447
label: Dietary Intervention
therapeutic_modality: BEHAVIORAL
role: preventive
evidence:
- reference: PMID:27534694
reference_title: "Necrotizing enterocolitis: new insights into pathogenesis and mechanisms."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
the use of standardized feeding guidelines (for example, patient-specific
orders with set thresholds to manage feeding intolerance)126 have been
implemented in multiple centres and have been proven to be effective to
reduce the incidence and severity of the disease
explanation: >-
Supports standardized feeding guidelines as an effective preventive
measure, and describes the form they take.
- reference: PMID:34427330
reference_title: "Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants."
supports: REFUTE
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
Meta-analyses showed that slow advancement of enteral feed volumes probably
has little or no effect on the risk of NEC (RR 1.06, 95% confidence
interval (CI) 0.83 to 1.37
explanation: >-
Refutes the specific proposition that cautious volume advancement prevents
NEC, over 14 trials and 4,026 infants at moderate certainty. Recorded as
REFUTE rather than omitted because slow advancement is a widely used
practice that this evidence does not support.
- reference: PMID:34427330
reference_title: "Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants."
supports: REFUTE
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
Advancing the volume of enteral feeds at a slow rate may slightly increase
the risk of invasive infection.
explanation: >-
The review's own conclusion that slow advancement may carry net harm,
supporting the caveat recorded in this treatment's description.
notes: >-
Two claims are kept deliberately separate here because the literature
separates them: standardized feeding practice reduces NEC, while slow volume
advancement specifically does not. Conflating them would read the positive
quality-improvement result as evidence for a practice that randomized trials
do not support.
- name: Bowel Rest, Gastric Decompression and Broad-Spectrum Antibiotics
description: >-
Standard medical management of Bell stage II disease: enteral feeds are
stopped, the stomach is decompressed by nasogastric tube, intravenous fluids
are given, and broad-spectrum antibiotic cover is started. Combination
antimicrobial therapy has been the standard since the original staging
series, which cultured enteric organisms including anaerobes from these
infants.
treatment_term:
preferred_term: broad-spectrum antibiotic therapy
term:
id: NCIT:C15620
label: Antibiotic Therapy
therapeutic_agent:
- preferred_term: ampicillin
term:
id: CHEBI:28971
label: ampicillin
- preferred_term: gentamicin
term:
id: CHEBI:759884
label: gentamicin
- preferred_term: metronidazole
term:
id: CHEBI:6909
label: metronidazole
role: standard of care
notes: >-
The three agents bound here are named as the common empiric combination in
the treatment literature surveyed for this entry rather than quoted from a
trial comparing regimens; no head-to-head antibiotic regimen trial in NEC
was read for this entry, and antibiotic choice in NEC remains a stewardship
question rather than a settled one.
target_mechanisms:
- target: Systemic Inflammatory Response and Sepsis
description: >-
Antimicrobial cover addresses the bacteraemia from translocated enteric
organisms.
evidence:
- reference: PMID:413500
reference_title: "Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
Bacteriologic evaluation of the gastrointestinal microflora in these
neonates has revealed a wide range of enteric organisms including
anaerobes.
explanation: >-
The organisms recovered are the rationale for combination cover
including anaerobic activity. INDIRECT because the inference runs from
the organisms present to the choice of regimen.
evidence:
- reference: PMID:27534694
reference_title: "Necrotizing enterocolitis: new insights into pathogenesis and mechanisms."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
Medical management, such as nasograstric decompression, intravenous fluids
and broad-spectrum antibiotics Close clinical, laboratory and radiographic
observation
explanation: >-
The Bell stage II treatment column states exactly the components of
medical management this treatment records. The source's spelling of
"nasograstric" is kept because a snippet is not corrected.
- reference: PMID:413500
reference_title: "Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: PRIMARY_RESULT
snippet: "These studies support the use of combination antimicrobial therapy in the treatment of infants with NEC."
explanation: >-
The originating series' own conclusion supporting combination
antimicrobial therapy.
- name: Parenteral Nutrition
description: >-
Because enteral feeds are withheld for the duration of the acute illness and
absorptive capacity may be permanently reduced, parenteral nutrition is
required through the acute phase and, in infants left with short bowel
syndrome, for far longer. Prolonged dependence carries its own cost in
cholestasis.
treatment_term:
preferred_term: Total Parenteral Nutrition
term:
id: NCIT:C29484
label: Total Parenteral Nutrition
role: supportive
evidence:
- reference: PMID:30864508
reference_title: "Necrotizing Enterocolitis: Long Term Complications."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
cholestasis, short bowel syndrome with or without intestinal failure that
can be difficult to manage
explanation: >-
Names the intestinal failure that makes parenteral nutrition necessary and
the cholestasis that accompanies prolonged dependence.
- name: Laparotomy with Resection of Necrotic Bowel
description: >-
Operative management of Bell stage III disease. The goals are to control
enteric spillage and resect necrotic intestine while preserving as much
viable length as possible, since residual length determines the risk of
short bowel syndrome. Radiographic pneumoperitoneum is the only absolute
indication.
treatment_term:
preferred_term: laparotomy with resection of necrotic bowel
term:
id: NCIT:C15329
label: Surgical Procedure
therapeutic_modality: SURGERY
role: standard of care
target_mechanisms:
- target: Transmural Necrosis and Intestinal Perforation
description: >-
Resection removes the necrotic segment and closes the source of enteric
spillage, which is the lesion this node names.
evidence:
- reference: PMID:27836422
reference_title: "Surgical necrotizing enterocolitis."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: "The primary goals of surgical intervention in NEC are to control enteric spillage and/or resect necrotic intestine while maximizing the length of viable intestine."
explanation: >-
States the operative goals against exactly the lesion this target node
represents.
evidence:
- reference: PMID:27836422
reference_title: "Surgical necrotizing enterocolitis."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: "Evidence of pneumoperitoneum on plain radiography is the only absolute criteria for operative intervention."
explanation: >-
States the single absolute operative indication recorded in this
treatment's description.
- reference: PMID:27534694
reference_title: "Necrotizing enterocolitis: new insights into pathogenesis and mechanisms."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
Exploratory laparotomy and resection of necrotic bowel Peritoneal drainage
in selected cases
explanation: >-
The Bell stage III treatment column names laparotomy with resection as the
management of advanced disease, with peritoneal drainage as the selected
alternative curated separately below.
- name: Primary Peritoneal Drainage
description: >-
Bedside peritoneal drain placement as the initial surgical intervention, used
particularly in the smallest and least stable infants. Pooled evidence shows
no mortality difference against primary laparotomy, so either can be chosen
in selected patients; a substantial fraction of drained infants subsequently
require laparotomy.
treatment_term:
preferred_term: primary peritoneal drainage
term:
id: NCIT:C15329
label: Surgical Procedure
therapeutic_modality: SURGERY
role: alternative
evidence:
- reference: PMID:35451633
reference_title: "Initial surgical treatment of necrotizing enterocolitis: a meta-analysis of peritoneal drainage versus laparotomy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: "There was no significant difference in mortality between peritoneal drainage and laparotomy as initial surgical intervention."
explanation: >-
The meta-analysis conclusion recorded in this treatment's description.
- reference: PMID:35451633
reference_title: "Initial surgical treatment of necrotizing enterocolitis: a meta-analysis of peritoneal drainage versus laparotomy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
The results suggest that either intervention could be used in selected
patients.
explanation: >-
Supports the equipoise this treatment's description records.
notes: >-
The meta-analysis pooled NEC with spontaneous intestinal perforation, which
the authors list among their own stated limitations. That is a limitation of
the evidence for this treatment, not a claim that the two entities are the
same.
- name: Enterostomy
description: >-
Diverting stoma formation at laparotomy, used when primary anastomosis is
unsafe. Stoma complications are common in this population, including
prolapse, stricture and retraction, and proximal jejunostomies cause
substantial fluid and electrolyte losses.
treatment_term:
preferred_term: Enterostomy
term:
id: NCIT:C52005
label: Enterostomy
therapeutic_modality: SURGERY
role: standard of care
evidence:
- reference: PMID:27534694
reference_title: "Necrotizing enterocolitis: new insights into pathogenesis and mechanisms."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: >-
Most common include: prolapse, stricture and retraction Proximal
jejunostomies can cause substantial electrolyte and fluid losses, impaired
weight gain and peristomal skin complications
explanation: >-
The complications table row enumerates exactly the stoma complications
this treatment's description records.
clinical_burden:
burden_level: HIGH
rationale: >-
NEC is the leading cause of death from gastrointestinal disease in preterm
infants, with mortality of 30-50% in advanced disease and 43% at thirty days
among infants requiring surgery. Survivors carry intestinal stricture, short
bowel syndrome and neurodevelopmental impairment at rates well above those of
preterm infants without NEC.
evidence:
- reference: PMID:40953322
reference_title: "Exploring the Complex Pathophysiology of Necrotizing Enterocolitis in Preterm Neonates."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: "Necrotizing enterocolitis (NEC) is the most common gastrointestinal emergency in preterm neonates, with a mortality rate of 30-50% in advanced cases."
explanation: >-
Gives both the epidemiological standing and the advanced-disease mortality
quoted in this rationale.
- reference: PMID:35554890
reference_title: "Necrotizing Enterocolitis in Very Low Birth Weight Neonates: A Natural History Study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: "Thirty-day mortality was much greater among surgical NEC patients (medical NEC 16.4% vs. surgical NEC 43.0%), as were rates of various in-hospital and long-term outcomes."
explanation: >-
Gives the stage-specific thirty-day mortality figures quoted in this
rationale from a contemporary multicentre cohort.
discussions:
- discussion_id: nec_paneth_cell_hypothesis
kind: CONTROVERSY
status: OPEN
prompt: >-
Does Paneth cell loss or dysfunction precede and contribute to NEC, or is
the Paneth cell change observed in resected bowel a consequence of the
disease and its repair?
rationale: >-
Paneth cell dysfunction has been a standing hypothesis for NEC pathogenesis,
on the reasoning that loss of alpha-defensin output would remove a control
on the colonizing community. The one human tissue series read for this entry
points the other way at the time that matters: Paneth cell abundance in
acute NEC did not differ from preterm controls, and hyperplasia with raised
alpha-defensin 5 appeared only after recovery. That is compatible with a
reparative rather than causal role. No Paneth cell node is curated in the
pathograph for this reason.
attaches_to:
- pathophysiology#Abnormal Microbial Colonization of the Preterm Gut
evidence:
- reference: PMID:21372757
reference_title: "Paneth cell hyperplasia and metaplasia in necrotizing enterocolitis."
supports: REFUTE
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: "In acute NEC, Paneth cell abundance in small intestinal tissue was not significantly different from preterm controls."
explanation: >-
Contradicts a depletion-at-onset version of the Paneth cell hypothesis in
human resected tissue, which is the specific claim this controversy turns
on.
- reference: PMID:21372757
reference_title: "Paneth cell hyperplasia and metaplasia in necrotizing enterocolitis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
After recovery from NEC, Paneth cell hyperplasia was observed in the small
intestine concomitant with elevated human alpha-defensin 5 mRNA levels.
explanation: >-
The post-recovery hyperplasia with raised alpha-defensin 5 is the
observation that keeps the Paneth cell compartment mechanistically
interesting, on a reparative reading rather than a causal one.
- discussion_id: nec_heritable_component
kind: KNOWLEDGE_GAP
status: OPEN
prompt: >-
Is there a heritable component to NEC risk over and above the heritability of
prematurity itself, and is the twin concordance signal genetic or shared
environmental?
rationale: >-
The evidence pulls both ways in the same body of work. Zygosity and same-sex
concordance data in twins point at shared genetic and environmental
contributions, and preterm twin faecal microbiome data are consistent with
that. Against it, studies that controlled for gestational age found no
difference between twins and singletons - which is the comparison that
matters, because twins are born earlier and prematurity is the dominant risk
factor in this disease. Twin concordance also cannot separate genes from a
shared uterine, feeding and microbial environment, and the monochorionic
excess is conventionally attributed to placental vascular anatomy rather than
to genotype. SIGIRR is the one locus with human loss-of-function variants plus
functional corroboration, and even there the supporting cohort has no control
group. Resolving this needs cohorts large enough to estimate a variant effect
against matched preterm controls, not further concordance counting.
attaches_to:
- genetic#SIGIRR
evidence:
- reference: PMID:39949097
reference_title: "Twins and Necrotizing Enterocolitis: Genetic Relevance."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
directness: INDIRECT
snippet: >-
Same sex concordance and zygosity data suggest shared genetic and
environmental factors as important contributing factors to the pathogenesis
of NEC.
explanation: >-
States the concordance argument for a heritable contribution, and states it
as genetic and environmental factors jointly rather than as a genetic
effect, which is the ambiguity this gap turns on.
- reference: PMID:39949097
reference_title: "Twins and Necrotizing Enterocolitis: Genetic Relevance."
supports: REFUTE
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
directness: DIRECT
snippet: >-
However, there is also some uncertainty in these observations because
studies that controlled for gestational age did not show significant
differences between singletons and twins in the occurrence of NEC.
explanation: >-
The same review reports that adjusting for gestational age removes the
twin-singleton difference, which contradicts reading the concordance signal
as evidence of a heritable component independent of prematurity.
- reference: PMID:39949097
reference_title: "Twins and Necrotizing Enterocolitis: Genetic Relevance."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
directness: DIRECT
snippet: >-
There is a need for further evaluation of genetic and confounding factors
arising from the environment and the gut microbiome in these infants using
cohorts with larger sample sizes.
explanation: >-
The review's own statement that the question is open and what would settle
it, which is what this gap records.
- discussion_id: nec_white_matter_injury_causality
kind: KNOWLEDGE_GAP
status: OPEN
prompt: >-
Is the excess of periventricular leukomalacia and neurodevelopmental
impairment after NEC caused by the disease's systemic inflammatory response,
or is it confounded by gestational age, illness severity and interrupted
nutrition?
rationale: >-
The association is large, replicated and graded by disease severity, and a
plausible mediator route exists in the circulating cytokine load. None of
that establishes causation from observational data: the infants who develop
surgical NEC are also the sickest and the most nutritionally deprived, and
the meta-analysis that supplies the effect estimates says in its own
conclusion that causality is not established. Resolving it would need
mediation analysis against measured inflammatory mediators, or a preventive
trial powered on neurodevelopmental rather than intestinal outcomes.
attaches_to:
- pathophysiology#Cerebral White Matter Injury
- phenotypes#Neurodevelopmental delay
evidence:
- reference: PMID:38684534
reference_title: "Neurodevelopmental outcomes of preterm with necrotizing enterocolitis: a systematic review and meta-analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
Further high-quality studies with comprehensive adjustments for potential
confounding factors are required to definitively establish whether the
association with NDI is causal.
explanation: >-
The meta-analysis states the open question this gap records, in its own
words, and names residual confounding as the reason it is open.
- reference: PMID:37493095
reference_title: "Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
Probiotics may have little or no effect on neurodevelopmental impairment
(RR 1.03, 95% CI 0.84 to 1.26
explanation: >-
An intervention that reduces NEC does not measurably reduce
neurodevelopmental impairment in the five trials reporting it, which is
weak evidence against a simple NEC-causes-impairment model. INDIRECT and
low-powered: five trials and 1,518 infants, graded low certainty.
references:
- reference: PMID:35347256
title: "Bench to bedside - new insights into the pathogenesis of necrotizing enterocolitis."
- reference: PMID:27534694
title: "Necrotizing enterocolitis: new insights into pathogenesis and mechanisms."
- reference: PMID:40953322
title: "Exploring the Complex Pathophysiology of Necrotizing Enterocolitis in Preterm Neonates."
- reference: PMID:38564081
title: "Neonatal Necrotizing Enterocolitis: An Update on Pathophysiology, Treatment, and Prevention."
- reference: PMID:17878380
title: "A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair."
- reference: PMID:23650378
title: "Endothelial TLR4 activation impairs intestinal microcirculatory perfusion in necrotizing enterocolitis via eNOS-NO-nitrite signaling."
- reference: PMID:25899687
title: "Breast milk protects against the development of necrotizing enterocolitis through inhibition of Toll-like receptor 4 in the intestinal epithelium via activation of the epidermal growth factor receptor."
- reference: PMID:26969089
title: "Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study."
- reference: PMID:33328245
title: "Human milk oligosaccharide DSLNT and gut microbiome in preterm infants predicts necrotising enterocolitis."
- reference: PMID:33330904
title: "Necrotizing Enterocolitis and the Microbiome: Current Status and Future Directions."
- reference: PMID:18346531
title: "The neonatal intestinal vasculature: contributing factors to necrotizing enterocolitis."
- reference: PMID:36864828
title: "Imaging for Diagnosis and Assessment of Necrotizing Enterocolitis."
- reference: PMID:27836422
title: "Surgical necrotizing enterocolitis."
- reference: PMID:413500
title: "Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging."
- reference: PMID:35554890
title: "Necrotizing Enterocolitis in Very Low Birth Weight Neonates: A Natural History Study."
- reference: PMID:39239939
title: "Donor human milk for preventing necrotising enterocolitis in very preterm or very low-birthweight infants."
- reference: PMID:32384652
title: "The Impact of Human Milk on Necrotizing Enterocolitis: A Systematic Review and Meta-Analysis."
- reference: PMID:37493095
title: "Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants."
- reference: PMID:35451633
title: "Initial surgical treatment of necrotizing enterocolitis: a meta-analysis of peritoneal drainage versus laparotomy."
- reference: PMID:38684534
title: "Neurodevelopmental outcomes of preterm with necrotizing enterocolitis: a systematic review and meta-analysis."
- reference: PMID:30864508
title: "Necrotizing Enterocolitis: Long Term Complications."
- reference: PMID:21372757
title: "Paneth cell hyperplasia and metaplasia in necrotizing enterocolitis."
- reference: PMID:34427330
title: "Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants."
- reference: PMID:25963006
title: "SIGIRR genetic variants in premature infants with necrotizing enterocolitis."
- reference: PMID:39949097
title: "Twins and Necrotizing Enterocolitis: Genetic Relevance."
- reference: PMID:31375667
title: "A murine neonatal model of necrotizing enterocolitis caused by anemia and red blood cell transfusions."
Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.
Review round 1: rebind two terms, add SIGIRR susceptibility, commit deep-research report · 2026-09-30T03:24:46Z · View source
Review round addressing the CHANGES_REQUESTED review on PR #13195. Two ontology bindings were wrong and are corrected. 1. `phenotypes[Ileal stricture]` was bound to `HP:0020002 Ileal stricture` under a `notes:` claim that HPO has no generic intestinal-stricture class. That claim was false, and false in an instructive way: the original search had only ever used the word *stricture*, and HPO names this concept by the word *stenosis*. Re-running against OLS HP, `l~stenosis` returns `HP:0012851 Colonic stenosis` and `l~intestinal stenosis` returns `HP:0012848 Small intestinal stenosis`. The row is renamed to `Post-NEC intestinal stricture` and rebound to `HP:0012851`, the colon being the site the cited review puts up to 80% of post-NEC strictures in - a figure that turned out to be quotable from the same complications-table row the entry already cited, and which is now recorded as evidence rather than asserted in prose. The `notes:` field is rewritten to record every query verbatim and what each returned. `HP:0012848` is named there as the term that would carry the non-colonic minority, but no source read for this entry names or quantifies the small-bowel share, so a second row is not asserted on the strength of the "up to 80%" complement alone. The rename dangled one bare-name pathograph target (`Coagulative Mucosal Necrosis and Intramural Gas Formation.downstream`), which is updated in the same edit. One incidental finding worth recording, because it would make a future negative-existence note false the same way: an `l~` search against OLS that returns exactly 50 results is truncated at the page limit, so a negative drawn from one is not a negative. `l~gas` returns 50 and misses `HP:6000377`, which `l~intramural` returns directly. This is noted in the entry beside the searches it affects. 2. `pathophysiology[Endothelial TLR4 Activation and Loss of eNOS-Dependent Vasodilation]` bound `GO:0061028 establishment of endothelial barrier` DECREASED. Nothing in the node, its description or either PMID:23650378 evidence item measured barrier establishment; both are about eNOS expression and NO-dependent perfusion. Rebound to `GO:0006809 nitric oxide biosynthetic process` DECREASED, which the upstream `Impaired Intestinal Microcirculatory Autoregulation` node already binds, with `preferred_term` carrying the eNOS specificity GO's label lacks. The deep-research artifact the review asked for is now committed as `research/Necrotizing_Enterocolitis-deep-research-claude_code.md` (1,683 lines, `provider: claude_code`, `template_sha` 1e7ea4ee817acfe1dda5f77fafe6f2e8b5927666, 27/27 references verified, 58/58 terms resolved). It must not be read as independent corroboration of this entry, and the reason is a matter of provenance rather than of quality. It was generated AFTER the entry was curated, and the provider had the committed entry and its reference cache available while writing. Overlap between the report and the YAML is therefore expected by construction and carries no evidential weight; where the report agrees with a curated claim, that agreement is not a second source. It is committed as a cross-check input and as a lead list, which is all the review asked of it. `just preflight-dr` returns SKIP rather than PASS: MONDO records no causal gene (`RO:0004003`) for MONDO:0005313, so the gene-identity discriminator has nothing to work with. That is the expected result for a non-Mendelian disease and not a degraded lookup. The manual identity check was done instead - the report's gene tally is TLR4=76, SIGIRR=21, NFKB1=4, LY96=4, which is this disease's mechanism and not a neighbouring one. The report's own term validation flags `HP:0006970`, which the report names "Necrotizing enterocolitis (the disease as an HP feature)" while HPO calls it Periventricular leukomalacia; this entry uses `HP:0006970` correctly for periventricular leukomalacia, and no CURIE was lifted from the report. Genetic susceptibility. The report surfaced four references the entry did not cite, three of them on a theme the entry said nothing about. Each was fetched and read. - PMID:25963006 (SIGIRR variants in premature infants with NEC) is cited, and a `genetic:` block is added on the strength of it: one record, SIGIRR, `relationship_type: SUSCEPTIBILITY`, `variant_origin: GERMLINE`, with two evidence items - the human sequencing result (10 of 17 stage II+ infants) and the in-vitro demonstration that the variants are loss-of-function and exaggerate the lipopolysaccharide response. The entry keeps `category: Complex`. This is deliberately option (a) over a notes-only answer, because SIGIRR is the one NEC locus with both human loss-of-function variants and functional corroboration, and because the mechanism it implicates is the TLR4 arm this entry is built around - losing the epithelial brake on TLR4 lowers the threshold at which a given luminal lipopolysaccharide load fires the node the pathograph already carries. What the record deliberately does NOT claim: `gene_disease_validity` is absent, because no external body has classified the pair and a tier is copied rather than assigned. The cohort is 17 sequenced infants with no matched preterm control group reported, so "10 of 17" is a variant frequency among cases and not an effect estimate; the `notes:` field says so, because the number reads like an association until you look for the denominator. NFKB1, LY96, IL18 and TLR4 itself are named in the disease notes as reviewed and not curated - nothing read here supplies a quotable human result for them. - PMID:39949097 (Twins and NEC: Genetic Relevance) is cited in a new `discussions` entry, `nec_heritable_component`, `kind: KNOWLEDGE_GAP`, attached to `genetic#SIGIRR`. The review cuts both ways within one abstract, so it is curated as three items and not one: concordance and zygosity data suggesting a heritable contribution (SUPPORT), the gestational-age-adjusted analyses that erase the twin-singleton difference (REFUTE), and the authors' own statement of what would settle it. Twins are born earlier and prematurity is this disease's dominant risk factor, so the adjusted comparison is the one that matters, which is why the gap is recorded as open rather than resolved in favour of heritability. - PMID:31375667 (murine anemia/RBC-transfusion NEC model) supports a new `environmental:` entry for transfusion-associated NEC, bound to `ECTO:2000058 exposure to blood transfusion`. Graded carefully: the clinical association is quoted from the paper's own background sentence as HUMAN_CLINICAL with `quote_role: BACKGROUND`, so a mouse study is not made to assert a human epidemiological link; the mechanism, the dose-response on anemia and the four protective interruptions are MODEL_ORGANISM and INDIRECT. The mechanism link targets `Mucosal Proinflammatory Cytokine Amplification` with `causal_link_type: INDIRECT_KNOWN_INTERMEDIATES`, because the model names the intermediates (macrophages, TLR4) rather than leaving them open, giving a third TLR4-dependent input into a node the epithelial and endothelial arms already converge on. `environmental_effect` is PREDISPOSES and not TRIGGERS even though the model demonstrates triggering: the human association is contested, and whether transfusion or the anemia behind it is the operative exposure is unresolved. The entry `notes:` records the iatrogenic tension - transfusion is a putative risk exposure at onset and a supportive treatment in established disease, and neither reading cancels the other. - PMID:41315724 ("Does genetic susceptibility play a role in necrotizing enterocolitis?") was fetched and is NOT cited. Its cache carries `content_type: unavailable` with an empty body: PubMed holds no abstract for this 2026 commentary, so there is nothing quotable in it and its title is a question rather than a finding. The cache file was deleted rather than committed uncited. Suggestions taken from the review. - `Probiotic Supplementation` gains `therapeutic_modality: OTHER`, with a `notes:` line recording why not the `BEHAVIORAL` that `NCIT:C15447 Dietary Intervention` would suggest mechanically: a dose of live organisms given to alter the colonizing community is not a change in diet pattern, and this is the same reason the documented backfill table excludes nutritional-supplementation terms. - `Hematochezia`'s description said "gross or occult blood" against `HP:0002573`, which means visible blood. Rewritten to say visible blood and then to say explicitly that occult faecal blood also occurs and is deliberately outside what this row records, which is the clearer of the two options the review offered. - Two radiographic phenotypes are added and wired into the pathograph: `Portal venous gas` downstream of `Coagulative Mucosal Necrosis and Intramural Gas Formation`, and `Pneumoperitoneum` downstream of `Transmural Necrosis and Intestinal Perforation`. Both are left unbound, because HPO has neither concept. Every query is recorded in the respective `notes:` field with a positive control on the same adapter in the same session (`l~intramural` returns `HP:6000377`; `l~Hematochezia` returns `HP:0002573`), so the negative is demonstrably about HPO's coverage rather than a dead lookup. The searches were: `l~pneumoperitoneum`, `l~pneumatosis`, `l~free air`, `l~intraperitoneal`, `l~peritoneal gas`, `l~peritoneal`, `l~air`, `l~portal venous gas`, `l~hepatoportal`, `l~portal`. - Acid suppression is added as two `environmental:` entries rather than one, `Proton pump inhibitor exposure` (`ECTO:2000019`) and `Histamine H2 receptor antagonist exposure` (`ECTO:9001771 exposure to histamine antagonist`, broader than H2 with the specificity carried in `preferred_term`). ECTO has no class covering acid suppression as a whole - `l~antiulcer`, `l~gastric acid` and `l~acid suppress` each return nothing - so a single entry would have had to bind one class and silently cover the other. The two share their supporting sentence from PMID:38564081 because the review names both classes in one breath and separates neither. Gates, all run separately and all passing on this tree: `just validate` (107 snippets, 133 titles, 0 issues), `just count-verified-snippets` (107/107), `just validate-terms`, `just validate-disorders` (the authoritative batched sweep), `check-duplicate-keys`, `check-entity-refs`, `check-causal-targets`, `check-qualifier-terms`, `check-enum-values`, `check-environmental-evidence` (the hard gate, with three new exposures each carrying their own entry-level evidence and no waiver used), `check-folded-hyphens`, `check-snippet-length`, `check-title-snippets`, `check-snippet-grading`, `check-coarse-phenotypes`, `check-reference-titles`, `check-case-collisions`, `check-not4curation`. `just list-disconnected-phenotypes` reports 16 of 16 phenotypes causally connected after the two additions. No baseline file was modified. Term caches gained four validator-written rows: `HP:0012851`, `ECTO:2000019`, `ECTO:9001771` and `hgnc:30575`, plus their enum-membership rows. `HP:0020002` remains in `cache/hp/terms.csv` now that nothing binds it; that row is validator-derived and is deliberately left alone.
Create: Necrotizing Enterocolitis · 2026-09-29T23:45:34Z · View source
De novo creation of kb/disorders/Necrotizing_Enterocolitis.yaml, anchored on MONDO:0005313. Curated as `category: Complex` with no `genetic:` block: NEC is a multifactorial disease of prematurity and no gene meets this KB's bar for a causal record, so the section was omitted rather than filled with a nominal susceptibility locus. No deep-research report exists for this disease. Every reference was found by independent PubMed search (NCBI E-utilities esearch/esummary over the pathophysiology, TLR4, microbiome, human-milk, probiotic, staging, surgical, imaging and neurodevelopmental literatures), triaged on title and journal, then fetched with `just fetch-reference` and quoted only from the resulting references_cache file. 23 references fetched, 23 cited, 88 evidence snippets. No reference was cited without its cache body being read first. Content curated: 15 pathophysiology nodes covering prematurity as the substrate, the two arms of TLR4 signalling (epithelial apoptosis with arrested restitution; endothelial eNOS loss with microcirculatory hypoperfusion), abnormal preterm colonization decomposed into a community-structure node and a Gammaproteobacterial-bloom/LPS-load node per the microbiome-curation skill, barrier failure with translocation, mucosal cytokine amplification, coagulative necrosis with intramural gas, transmural necrosis with perforation, systemic inflammation/sepsis, and cerebral white matter injury. 14 phenotypes, all 14 causally connected to the pathograph (verified with `just list-disconnected-phenotypes`). Bell staging curated as a `definitions` DIAGNOSTIC_CRITERIA record plus three `stages` entries. Two prevalence records (medical and surgical NEC, same contemporary US cohort, denominator stated as the at-risk preterm population). One histopathology finding. Two environmental exposures with `influences_mechanisms` links. Eight treatments, one of which (standardized feeding regimen) carries REFUTE evidence against slow enteral volume advancement. One `clinical_burden` record. Two `discussions`: a CONTROVERSY on the Paneth cell hypothesis (carrying a REFUTE item, because the human tissue series read here finds Paneth cell abundance unchanged in acute NEC) and a KNOWLEDGE_GAP on whether the post-NEC neurodevelopmental excess is causal. Module conformance: two nodes conform to `intestinal_barrier_dysfunction` (#Epithelial Stress and Injury, #Luminal Access and Inflammatory Amplification). Modules considered and rejected, with reasons recorded in the entry's `notes`: `gut_dysbiosis` (an aging hallmark scoped to age-associated microbiota drift feeding inflammaging, the wrong direction of life course for neonatal colonization), `epithelial_barrier_dysfunction` (models the type 2 allergic barrier hypothesis, terminating in IgE class switch and the atopic march), `neuroinflammation_glial_activation` (its central node is a reactive microglial and astrocytic state, and no source read for this entry measures glial activation in the brains of infants with NEC). No ischemia-reperfusion module exists in `kb/modules/`, so the microcirculatory nodes are curated de novo. Every ontology identifier was looked up at the time of writing, none from memory: MONDO:0005313 via OLS (label and non-obsolete status confirmed); HP, GO, CL, UBERON, NCBITaxon and NCIT terms via OLS search plus the committed `cache/<prefix>/terms.csv` labels; ECTO:9001757 via `runoak -i sqlite:obo:ecto`. Two bindings were deliberately left absent after recorded searches, both documented in `notes`: the preterm-formula exposure (ECTO has no infant-formula or human-milk feeding class) and the short bowel syndrome phenotype (HPO's only short-bowel term, HP:0030889, is congenital). An earlier draft bound short bowel syndrome to HP:0005214 Intestinal obstruction; that was removed as a wrong binding rather than carried with a coarse-binding basis. `HP:6000377 Intramural intestinal gas` was confirmed to carry "Pneumatosis intestinalis" as a synonym before use. Validation, each run separately and read: `just validate` (schema + terms + references) passed with 88/88 snippets verified and 111 titles checked, 0 issues; `just validate-disorders` (the authoritative batched gate) passed; `just count-verified-snippets` 88/88; `just check-duplicate-keys`, `check-entity-refs`, `check-causal-targets`, `check-qualifier-terms`, `check-enum-values`, `check-environmental-evidence`, `check-snippet-length`, `check-title-snippets`, `check-snippet-grading`, `check-folded-hyphens`, `check-coarse-phenotypes`, `check-reference-titles` and `validate-history-all` all OK with no new findings and no baseline changed. The stub `stubs/Necrotizing_Enterocolitis.yaml` is deleted in the same commit.
Disease: Necrotizing Enterocolitis MONDO ID: MONDO:0005313 Category: Complex (multifactorial disease of prematurity) Report date: 2026-09-29 Purpose: Curation input for a dismech disease entry (pathophysiology causal chain, phenotype/anatomy/chemical/treatment bindings, evidence items)
This report separates three tiers of quotation reliability, because the distinction matters for downstream evidence curation:
| Tier | Meaning | How to treat |
|---|---|---|
| [KB-VERIFIED] | The quoted string is already committed in kb/disorders/Necrotizing_Enterocolitis.yaml and has passed linkml-reference-validator against the local references_cache/ copy of the cited reference. |
Usable directly as an evidence snippet:. |
| [ABSTRACT-VERBATIM] | Quoted from an abstract retrieved in this session through the NCBI E-utilities efetch endpoint (rettype=abstract&retmode=text), which returns the raw abstract text. |
Usable as a snippet after one just fetch-reference PMID:<id> + just count-verified-snippets round-trip. |
| [SUMMARIZER-DERIVED] | The figure or claim is correct per the retrieval, but the wording passed through a summarization step and is not confirmed to be an exact substring. | Do not paste as a snippet. Re-fetch and re-quote before curating. |
Every CURIE in this report was read from a source in the same step it was written — specifically, from the already-validated bindings in the committed NEC knowledge-base entry (which has passed just validate-terms), not from recall. CURIEs I could not source that way are explicitly marked unbound / needs lookup rather than guessed.
| Field | Value | Source |
|---|---|---|
| Preferred label | Necrotizing enterocolitis | MONDO |
| MONDO | MONDO:0005313 | KB-validated disease_term |
| Common abbreviation | NEC | Universal in the literature |
| Disease category | Complex / multifactorial; a disease of prematurity rather than a Mendelian disorder | See §4 |
I was unable to retrieve authoritative OMIM, Orphanet, ICD-10-CM, ICD-11, MeSH, UMLS, or DOID identifiers for NEC in this session through a source I could quote. These are stated as unavailable rather than supplied from memory, per the project's identifier rule. Curators should resolve them from MONDO's own xref block:
uv run runoak -i sqlite:obo:mondo info MONDO:0005313
# or, for the cross-references table:
just fetch-reference ORPHA:<code> # once the ORPHA code is confirmed from MONDO xrefs
Notes on what to expect: - OMIM: NEC has historically carried an OMIM phenotype entry for "necrotizing enterocolitis susceptibility," but I could not confirm the MIM number from a quotable source. Treat as unconfirmed. - Orphanet: NEC is not a rare disease by Orphanet's prevalence criteria in the preterm population it affects (it occurs in ~5–10% of very-low-birth-weight infants — see §9), so an ORPHA code may not exist. Verify rather than assume. - ICD-10-CM: the NEC codes sit in the P77.- block (perinatal conditions). Exact subcodes unconfirmed here.
NEC has no gold-standard diagnostic definition, and this is an active, unresolved problem in the field rather than a historical footnote. Three points a curator must handle deliberately:
"Thirty-eight neonates with necrotizing enterocolitis (NEC) were treated during a 12-month period. Based upon assessment of historical, clinical and radiographic findings, NEC was classified into three stages" — Bell et al., Ann Surg 1978. PMID:413500 [KB-VERIFIED] (human clinical)
Bell staging and its "modified" successor conflate a suspicion tier (stage I) with definite disease (stage II, pneumatosis intestinalis) and advanced disease (stage III, perforation/shock). Stage I is non-specific: it captures feeding intolerance of any cause.
"NEC" as used in trials and registries is heterogeneous. Because stage I is non-specific and stage II depends on radiographic interpretation of pneumatosis (which has poor inter-rater reliability), reported incidences and treatment effects are not strictly comparable across studies. A curator quoting an incidence or a relative risk should record the definition used in notes:.
Spontaneous intestinal perforation (SIP) is a separate disease and is frequently misclassified as NEC. SIP is a focal, typically ileal perforation in extremely preterm infants, often in the first week, without the antecedent pneumatosis, feeding history, or coagulative necrosis of NEC. Including SIP in a NEC cohort dilutes every mechanistic signal. This matters for dismech scope: SIP is a candidate for its own entry, and the NEC entry should not absorb it.
There is an active push (Delphi consensus processes, "two-step" definitions separating a screening tier from a confirmatory tier) to replace Bell staging. I could not retrieve a specific consensus publication with a quotable abstract in this session. Flagged as a gap: a curator should search for the current NEC definitional consensus before finalizing definitions: entries, and should consider a discussions: entry with kind: KNOWLEDGE_GAP attached to disease# recording that the case definition is contested.
NEC is not caused by a single agent. It is the convergence of four to five conditions, none individually sufficient. The canonical formulation is: prematurity + enteral feeding + abnormal bacterial colonization + immature innate immune signalling + microcirculatory fragility.
(a) Prematurity — the dominant and near-necessary risk factor.
Risk is inversely proportional to gestational age and birth weight. NEC is overwhelmingly a disease of very-low-birth-weight (VLBW, <1500 g) and extremely-low-birth-weight (<1000 g) infants. The immature preterm intestine differs from the term intestine in ways that are each individually mechanistic (see §6): higher epithelial TLR4 expression, thinner and less cross-linked mucus, immature Paneth cell function, reduced IgA, weaker tight junctions, and immature microvascular autoregulation.
"Necrotizing enterocolitis (NEC) is the leading cause of death and disability from gastrointestinal disease in premature infants" — PMID:35347256 [KB-VERIFIED] (human clinical / review)
(b) Elevated intestinal epithelial TLR4 expression in the premature gut.
This is the single most mechanistically load-bearing "host" factor and the one with the strongest genetic and pharmacologic corroboration.
"TLR4 expression in the premature intestine is increased compared with the full-term intestine" — PMID:17878380 [KB-VERIFIED] (model organism + human tissue)
Developmental regulation of TLR4 is itself the point: TLR4 signalling in the fetal gut serves normal intestinal development, and the same receptor becomes pathogenic when the gut is colonized prematurely.
(c) Enteral feeding.
NEC is essentially unseen in infants who have never been fed enterally. Feeding provides the luminal substrate for bacterial proliferation. Formula feeding is a specific amplifier and human milk is protective (§2.4) — meaning the exposure is not "feeding" as a monolith but the composition of the feed.
(d) Abnormal microbial colonization (dysbiosis), not a specific pathogen.
Decades of searching for a single causative organism have failed. What is reproducible is a community-level abnormality: a bloom of Gammaproteobacteria (Enterobacteriaceae) with loss of obligate anaerobes, particularly Bifidobacterium.
"Gut dysbiosis, characterized by an increase in the relative abundance of Gammaproteobacteria, has been associated with NEC" — PMID:33328245 [KB-VERIFIED] (human clinical, microbiome)
Functional (rather than taxonomic) metagenomics supports this being mechanistic rather than incidental: the pre-NEC metagenome is enriched for LPS O-antigen biosynthesis, type IV secretion systems, L-rhamnose utilization, quorum-sensing systems, and bacterial iron-transport machinery — i.e. for exactly the functions that would raise luminal LPS load and epithelial adhesion/invasion capacity.
(e) Microcirculatory dysregulation.
The ischemic component of NEC is now understood as secondary to inflammatory endothelial dysfunction rather than as a primary hypoxic-ischemic insult (the older "asphyxia → gut ischemia" model). The evidence is direct:
"Endothelial TLR4 activation impairs intestinal microcirculatory perfusion in necrotizing enterocolitis via eNOS-NO-nitrite signaling" — PMID:23650378 [KB-VERIFIED] (model organism)
This reverses the classical causal ordering: TLR4 signalling causes the hypoperfusion, rather than hypoperfusion causing inflammation.
NEC has no established Mendelian causal gene and is not inherited as a single-gene disorder. What exists is a set of susceptibility loci in innate-immune and TLR-pathway genes, mostly from candidate-gene and small-cohort studies, with the important exception of SIGIRR, which has human loss-of-function variants plus mechanistic corroboration.
SIGIRR (single Ig and TIR domain-containing) — the strongest candidate.
SIGIRR is a negative regulator of TLR4 signalling specifically enriched in intestinal epithelium. Rare loss-of-function variants have been identified in NEC patients, and this is mechanistically coherent: losing the brake on TLR4 in the premature gut is predicted to cause exactly the phenotype.
NFKB1 −94ins/delATTG promoter polymorphism. A functional promoter insertion/deletion affecting NF-κB expression; associated with NEC risk in candidate-gene studies. Effect sizes are modest and replication is incomplete.
LY96 (MD-2). Encodes the obligate TLR4 co-receptor for LPS recognition. Variants here are mechanistically plausible for the same reason SIGIRR is, but the human genetic evidence is thinner.
TLR4 itself. Despite the centrality of TLR4 to the mechanism, human TLR4 coding-variant association with NEC is not convincingly established. This is a notable asymmetry worth recording: the pathway is genetically implicated through its regulators (SIGIRR) more than through the receptor.
A chromosome 8 SNP cluster has been reported at odds ratio ~4.72 across a ~43-kb region in a NEC association analysis. The implicated gene(s) and the replication status were not confirmable in this session. Treat as a lead, not a finding.
GM2 activator protein (GM2A) has been reported in the NEC susceptibility literature. Mechanism unclear; low confidence.
Twin and heritability data are genuinely contradictory, and this is the honest state of the evidence rather than a gap in my search: - Some twin analyses report a substantially increased risk in the co-twin of an affected twin (figures around a ~50% relative increase have been reported). - At least one formal ACE (additive genetic / common environment / unique environment) variance-decomposition analysis found no detectable additive genetic component once gestational age and shared intrauterine environment were modelled. - There is an excess of NEC in monochorionic twins specifically, which points to shared placental circulation (an environmental/vascular explanation) rather than to genotype.
Curation guidance: record NEC's genetic architecture as susceptibility-only. Use relationship_type: SUSCEPTIBILITY (or RISK_FACTOR) for SIGIRR, NFKB1, LY96 — never CAUSATIVE, which the schema reserves for Definitive/Strong ClinGen-tier gene–disease validity. Do not populate gene_disease_validity for these unless an external body (ClinGen/GenCC) has actually classified the pair; leave it absent and explain in Genetic.notes per the "copied, never assigned" rule. I found no ClinGen Gene-Disease Validity assertion for any NEC gene in this session.
| Factor | Direction | Mechanistic route | Confidence |
|---|---|---|---|
| Formula feeding (vs human milk) | ↑ risk | Lacks HMOs, IgA, lactoferrin, growth factors; supports Enterobacteriaceae bloom | High |
| Prolonged/early empiric antibiotics | ↑ risk | Suppresses anaerobes → Gammaproteobacterial bloom; delays healthy colonization | Moderate–high |
| H2 blockers / proton pump inhibitors | ↑ risk | Gastric acid suppression permits bacterial overgrowth | Moderate |
| Packed RBC transfusion | ↑ risk (contested) | Anemia-primed macrophage activation by RBC degradation products via TLR4 (§2.5) | Moderate |
| Severe anemia | ↑ risk | Macrophage priming; possibly the true exposure behind transfusion association | Moderate |
| Rapid feeding advancement | ↑ risk | Substrate load exceeding immature digestive/absorptive capacity | Moderate |
| Hypoxia–ischemia / hemodynamic instability | ↑ risk | Microcirculatory injury; hypoxia–reoxygenation | Moderate |
| Patent ductus arteriosus (esp. with indomethacin) | ↑ risk | Diastolic mesenteric steal; COX inhibition | Moderate |
| Congenital heart disease | ↑ risk (and the main route to NEC in term infants) | Low mesenteric perfusion / diastolic runoff | Moderate–high |
| Cesarean delivery | ↑ risk (weak) | Altered initial colonization | Low |
| Absence of antenatal steroids | ↑ risk | Reduced intestinal maturation | Low–moderate |
| Maternal chorioamnionitis | ↑ risk (inconsistent) | Fetal inflammatory priming | Low |
| Hyperosmolar feeds / medications | ↑ risk | Direct mucosal osmotic injury | Low–moderate |
Bacterial-colonization exposure is already bound in the entry:
ECTO:9001757 — the validated exposure-term binding used for abnormal bacterial colonization exposure in the committed entry.(a) Human milk — the best-evidenced protective exposure.
Human milk feeding is associated with a substantially reduced NEC risk relative to formula (reported relative risk around 0.62) — PMID:32384652 [SUMMARIZER-DERIVED — re-quote before use] (human clinical, meta-analysis)
(b) Donor human milk, when mother's own milk is unavailable, also reduces NEC relative to formula (Cochrane 2024 reports RR ≈ 0.53) — PMID:39239939 [SUMMARIZER-DERIVED — re-quote before use] (human clinical, systematic review)
Mechanism: human milk supplies human milk oligosaccharides (prebiotic, and directly anti-adhesive), secretory IgA, lactoferrin, lysozyme, EGF and heparin-binding EGF-like growth factor, TGF-β, and — notably — it shifts colonization toward Bifidobacterium.
(c) Probiotics. See §13 for the full, and genuinely contested, picture.
Probiotic supplementation reduces NEC (reported RR ≈ 0.54) and all-cause mortality (RR ≈ 0.77) in preterm infants — Cochrane 2023, PMID:37493095 [SUMMARIZER-DERIVED — re-quote before use] (human clinical, systematic review)
(d) Standardized feeding protocols. A non-pharmacologic quality-improvement intervention with consistent observational benefit — arguably the highest-yield, lowest-risk preventive measure available.
(e) Bifidobacterium longum subsp. infantis colonization, specifically in the context of HMO-rich human milk. Loss of Bifidobacterium is one of the most reproducible features of the pre-NEC microbiome.
(f) Haptoglobin — mechanistically protective in the transfusion-NEC model by chelating free hemoglobin/heme degradation products before they can activate macrophage TLR4. (model organism; not a clinical therapy)
(g) Antenatal corticosteroids, indirectly, via reduced prematurity morbidity broadly.
NEC is, mechanistically, an interaction disease — the interactions are the pathogenesis, not a refinement of it.
Prematurity × colonization × feeding. High epithelial TLR4 (developmental) + a Gammaproteobacteria-dominated community (microbial) + luminal substrate (feeding) → the core TLR4 hyperactivation node. Remove any one and the disease largely does not occur. This is the central three-way interaction.
SIGIRR loss-of-function × luminal LPS load. A SIGIRR-hypomorphic infant has a lower threshold for the same LPS exposure. This is the cleanest gene–environment model in NEC and is the one a dismech discussions: or mechanistic_hypotheses: block should capture.
Anemia × transfusion → macrophage activation. The "transfusion-associated NEC" literature resolves into a two-hit model: anemia primes intestinal macrophages, and RBC degradation products from transfusion then activate them through TLR4. Which of the two hits carries the causal weight is still argued — some large cohort analyses find anemia, not transfusion, to be the operative exposure. Record this as contested.
Antibiotics × colonization. Early empiric antibiotics are an environment → environment interaction: they act on NEC risk by reshaping the microbial exposure, not directly on the host.
Formula × microbiome. Formula's risk effect is at least partly mediated through the community it selects for, making feed type and dysbiosis non-independent exposures. Curators should avoid double-counting them as separate causal edges into the same node without saying so.
| Phenotype | HPO binding | Notes |
|---|---|---|
| Necrotizing enterocolitis (the disease as an HP feature) | HP:0006970 | Validated in entry |
| Abdominal distension | HP:0003270 | Validated; often the earliest sign |
| Vomiting / bilious emesis | HP:0002573 (validated binding in entry) | Feeding intolerance complex |
| Gastrointestinal hemorrhage / hematochezia | HP:0011968 (validated) — note: this CURIE is bound in the entry; confirm its exact HPO label before reuse | Bloody stools |
| Intestinal perforation | HP:0031368 (validated) | Stage IIIB |
| Pneumatosis intestinalis / intramural gas | HP:6000377 (validated) | The pathognomonic radiographic finding of stage II |
| Abdominal wall erythema / discoloration | see HP:0040187 (validated binding in entry) |
Advanced local disease |
| Ascites | Term not confirmed in this session | Late sign |
Feeding intolerance — increased gastric residuals, emesis, failure to advance feeds — is the commonest presenting complex but maps poorly to a single specific HPO term; it is also the least specific (it is Bell stage I, which is the non-specific tier). Curators should be careful not to bind a coarse term here without recording a coarse_binding_basis.
| Phenotype | HPO binding | Notes |
|---|---|---|
| Thrombocytopenia | HP:0001873 (validated) | Falling platelet count is a classic deterioration marker |
| Neutropenia | HP:0001942? — the entry binds HP:0001942 (metabolic acidosis) and HP:0020002; confirm which maps to which before reuse |
|
| Metabolic acidosis | HP:0001942 (validated in entry) | Marker of tissue hypoperfusion/necrosis |
| Disseminated intravascular coagulation | HP:0001976? not confirmed — needs lookup | Advanced disease |
| Sepsis / bacteremia | HP:0100806? not confirmed — needs lookup | Consequence of translocation |
| Shock / hypotension | HP:0001396? — the entry binds HP:0001396; confirm label |
Stage IIIA |
| Apnea | HP:0002104? not confirmed | Non-specific systemic instability |
| Temperature instability | not confirmed | Non-specific |
Caveat I must flag explicitly: four of the HP CURIEs above (HP:0011968, HP:0001942, HP:0001396, HP:0001508, HP:0012758) were harvested from the validated entry as a set, but I did not capture a one-to-one CURIE↔label mapping for each in a form I can reproduce here with confidence. They are all confirmed to be in the validated entry (so all exist and are enum-admissible), but a curator must re-read the entry to confirm which label each carries before reusing them for a different phenotype. Writing a label from memory here is precisely the failure mode CLAUDE.md forbids.
| Phenotype | HPO binding | Notes |
|---|---|---|
| Failure to thrive / growth failure | HP:0001508 (validated in entry) | Post-NEC, esp. after resection |
| Global developmental delay | HP:0012758 (validated in entry) | The major long-term morbidity |
| Cerebral white matter injury | no confirmed HP binding — modelled in the entry as a pathophysiology node rather than a phenotype | See §6 terminal branch |
| Cerebral palsy | not confirmed | Downstream of white matter injury |
This is a substantive and under-appreciated part of the NEC phenotype: surgical NEC survivors have markedly worse neurodevelopmental outcomes than gestational-age-matched controls, and the mechanism is thought to be systemic inflammation reaching the developing white matter ("gut–brain axis" in its inflammatory sense). The entry models this as a terminal causal node, which is the right structural choice.
Onset. Postnatal, not congenital. The characteristic pattern is an inverse relationship between gestational age and age at onset: the more premature the infant, the later NEC occurs. Extremely preterm infants typically present at 3–6 weeks of life (often around 29–32 weeks postmenstrual age); more mature preterm and term infants present in the first 1–2 weeks. This inverse relationship is one of the most distinctive epidemiologic features of the disease and is a strong argument for the colonization-maturation model (the gut must be colonized before it can be injured).
Relevant onset binding: HP:0003623-family neonatal-onset terms — not confirmed in this session; the entry's onset handling should be read directly.
Severity — Bell staging:
| Stage | Label | Defining features |
|---|---|---|
| I | Suspected NEC | Feeding intolerance, distension, occult blood; non-specific radiographs. Not definite disease. |
| IIA | Definite, mildly ill | Pneumatosis intestinalis on radiograph |
| IIB | Definite, moderately ill | + metabolic acidosis, thrombocytopenia, abdominal wall changes, portal venous gas or ascites |
| IIIA | Advanced, critically ill, bowel intact | Shock, DIC, respiratory/metabolic failure |
| IIIB | Advanced, bowel perforated | Pneumoperitoneum |
Progression. The clinically defining and most feared feature is fulminant progression: an infant can go from feeding intolerance to transmural necrosis, perforation, and shock within hours. This is not a slowly evolving disease, and that tempo is what makes the diagnostic-window problem acute. A substantial subset, however, is medical NEC that resolves with bowel rest.
Clinical course: PROGRESSIVE with temporality: ACUTE is the appropriate descriptor pairing for the acute illness; long-term sequelae (short bowel, strictures, neurodevelopmental impairment) are CHRONIC.
Frequency of individual phenotypes. I did not retrieve a quotable per-phenotype frequency table in this session. Curators should not populate HPO frequency qualifiers for NEC phenotypes from this report. The natural-history data I did retrieve is at the disease level (§11), not the phenotype level.
Severe, and it is bimodal. Medical NEC that resolves may leave little residual impact. Surgical NEC survivors face: - Short bowel syndrome / intestinal failure, with long-term parenteral nutrition dependence, central-line complications, and intestinal-failure-associated liver disease - Intestinal strictures requiring further surgery (a recognized late complication of resolved medical NEC too) - Stoma-related morbidity before reanastomosis - Growth failure and prolonged hospitalization (months) - Neurodevelopmental impairment, including cerebral palsy and cognitive delay - Family/caregiver burden from prolonged NICU stay and home parenteral nutrition
There is no Mendelian causal gene for NEC. This should be stated positively in the entry rather than left as an absence, because it is a real and curation-relevant fact: NEC is a multifactorial disease of prematurity in which genotype modifies susceptibility within an environmentally-determined at-risk population.
Concretely, this means:
- No gene should carry relationship_type: CAUSATIVE.
- No inheritance block asserting a Mendelian mode is appropriate. If an inheritance block is used at all, HP:0010982 Polygenic inheritance with relationship_type: SUSCEPTIBILITY gene typing is the defensible option — and even that overstates the evidence given the contradictory twin data (§2.2). Consider omitting inheritance: entirely and explaining in notes:.
- No ClinGen Gene-Disease Validity assertion was found for any NEC gene; gene_disease_validity should be absent, not filled with a curator-assigned tier.
| Gene | Variant(s) reported | Predicted consequence | Evidence tier | ACMG class |
|---|---|---|---|---|
| SIGIRR | p.Tyr168Ter (nonsense); p.Ser80Tyr (missense) — positions from literature, HGVS not normalized here | Loss of function → loss of TLR4 inhibition in intestinal epithelium | Human rare variants + mechanistic corroboration. Strongest candidate. | Not formally classified in any source I could quote. Do not assert. |
| NFKB1 | −94ins/delATTG promoter indel | Altered NF-κB expression | Candidate-gene association | N/A (regulatory, non-coding) |
| LY96 (MD-2) | Not specified in retrievable sources | Altered LPS co-receptor function | Weak | Unknown |
| TLR4 | — | — | Human association not established despite pathway centrality | — |
| Chromosome 8, ~43 kb SNP cluster | Multiple SNPs, reported OR ≈ 4.72 | Unknown; gene(s) unconfirmed | Single association analysis, replication unconfirmed | N/A |
| GM2A | Not specified | Unclear | Weak | Unknown |
Allele frequencies: not retrieved. gnomAD frequencies for the SIGIRR variants should be looked up directly before curation — they are expected to be rare (consistent with a rare-variant susceptibility model), but "expected" is not a source.
All NEC susceptibility variants discussed are germline. There is no somatic-mutation component to NEC — it is not a neoplastic or clonal disease. GeneticContext.variant_origin: GERMLINE is correct for any variant record.
For SIGIRR loss-of-function, the functional consequence is mechanistically specific and maps directly onto the pathophysiology chain:
Epithelial TLR4 Hyperactivation node in §6.functional_impact_category: LOSS_OF_FUNCTION is appropriate for the nonsense allele. For p.Ser80Tyr, PARTIAL_LOSS_OF_FUNCTION may be more accurate but requires a functional-assay source.The susceptibility genes in §4.2 are functionally modifiers of an environmentally-driven disease rather than modifiers of a primary genetic lesion — there is no primary lesion to modify. Curators should not create a separate "modifier" tier that implies one exists. If the schema's relationship_type: MODIFIER is used, record in notes that it modifies environmental risk.
The epigenetic literature on NEC is emerging and thin. Reported directions include: - Differential DNA methylation in intestinal tissue and in blood from NEC cases - microRNA dysregulation (including circulating miRNA explored as biomarkers) - Chromatin/epigenetic regulation of the developmental TLR4 expression programme in the immature gut — mechanistically the most interesting angle, since developmental downregulation of epithelial TLR4 is presumably epigenetically controlled
I could not retrieve a specific epigenetic study with a quotable abstract in this session. Stated as a gap. This is a legitimate discussions: kind: KNOWLEDGE_GAP candidate attached to pathophysiology#Elevated Intestinal Epithelial TLR4 Expression.
None. NEC has no recognized chromosomal syndrome association, no recurrent CNV, no aneuploidy association, and no structural-variant etiology.
Consequently, and to state the template's negatives explicitly: - Karyotyping: no role in NEC diagnosis. - Chromosomal microarray (CMA): no role. - FISH: no role. - Mitochondrial DNA testing: no role; NEC is not a mitochondrial disease. - Repeat-expansion testing: no role. - Clinical genetic testing generally: not indicated for NEC. Genetic findings are research-domain only. This is a meaningful negative for §10.
| Entity | Binding | Role |
|---|---|---|
| Lipopolysaccharide | CHEBI:16412 (validated) | The proximate TLR4 ligand; the luminal load rises with Gammaproteobacterial bloom |
| Nitric oxide | CHEBI:16480? — the entry binds CHEBI:16480-family NO; confirm | The vasodilator lost when endothelial eNOS signalling fails |
| Nitrite | CHEBI:16301? unconfirmed | The NO reservoir in the eNOS-NO-nitrite axis (PMID:23650378) |
| Endothelin-1 | peptide; CHEBI binding uncertain | The vasoconstrictor whose balance against NO shifts toward vasoconstriction |
| Sildenafil | CHEBI:759884 (validated in entry) | The pharmacologic probe/rescue for the microcirculatory node |
| (further CHEBI in entry) | CHEBI:28971, CHEBI:6909 | Validated bindings present in the entry; confirm which chemical each denotes |
The same caveat as §3.2 applies: CHEBI:16412, CHEBI:28971, CHEBI:759884 and CHEBI:6909 are all confirmed present and validated in the committed entry, but I have high confidence only on CHEBI:16412 = lipopolysaccharide and CHEBI:759884 = sildenafil. Read the entry for the other two rather than trusting a label I would be reconstructing.
Proteins central to mechanism (gene symbols; bind via lowercase hgnc: after lookup — I did not retrieve HGNC IDs in this session and will not supply them from memory):
TLR4, LY96/MD-2, SIGIRR, MYD88, NFKB1, NOS3 (eNOS), EDN1, IL6, IL8/CXCL8, IL1B, TNF, TLR9, HMGB1, and the biomarker proteins FABP2 (I-FABP), S100A8/S100A9 (calprotectin), KRT8 (fecal keratin 8), DEFB4A (human β-defensin 2), DEFA6 and GUCA2A (Paneth cell markers).
influences_mechanisms)| Exposure | environmental_effect |
Target node (§6) | Confidence |
|---|---|---|---|
Abnormal bacterial colonization of the preterm gut (ECTO:9001757) |
TRIGGERS | Abnormal Microbial Colonization / Gammaproteobacterial Bloom | High |
| Enteral formula feeding | TRIGGERS / EXACERBATES | Gammaproteobacterial Bloom and Increased Luminal LPS Load | High |
| Human milk feeding | PROTECTS_AGAINST | Gammaproteobacterial Bloom | High |
| Early/prolonged empiric antibiotics | PREDISPOSES | Abnormal Microbial Colonization | Moderate–high |
| Packed RBC transfusion | TRIGGERS (contested) | Mucosal Proinflammatory Cytokine Amplification | Moderate |
| Anemia | PREDISPOSES | Mucosal Proinflammatory Cytokine Amplification | Moderate |
| Hypoxia–ischemia | EXACERBATES | Microcirculatory Hypoperfusion and Mucosal Ischemia | Moderate |
| Gastric acid suppression (H2RA/PPI) | PREDISPOSES | Abnormal Microbial Colonization | Moderate |
| Hyperosmolar feeds/medications | EXACERBATES | Enterocyte Apoptosis and Failed Mucosal Restitution | Low–moderate |
| Probiotic supplementation | PROTECTS_AGAINST | Abnormal Microbial Colonization | Moderate (see §13) |
Note for curation: only TRIGGERS and EXACERBATES count as mechanistically explaining their target for compliance scoring. PREDISPOSES and PROTECTS_AGAINST are deliberately non-committal and will not connect a phenotype. Each influences_mechanisms link needs its own evidence separate from the environmental entry's general evidence, and check-environmental-evidence gates on the entry-level evidence.
Predominantly ingestion (enteral feeds, and the microbial community they support) and iatrogenic parenteral (transfusion, medications). There is no inhalational, dermal, or occupational exposure route relevant to NEC. Geographic/occupational exposure patterns do not apply to a neonatal intensive-care disease.
This chain is the structural spine of the disease. Each numbered step states the causal verb explicitly. Steps marked [INFERRED] are mechanistically reasoned rather than directly demonstrated in human NEC tissue; steps marked [MODEL] rest principally on animal or in vitro evidence. Branch points are marked ⑂.
Initiating conditions (necessary, jointly, not individually):
1. Premature birth produces an intestine that is developmentally immature in mucus, immunity, barrier, and vascular autoregulation.
→ node: Intestinal Immaturity of Prematurity
GO:0060576 (intestinal epithelial cell development, validated binding); UBERON:0002108 (small intestine, validated)
2. That developmental immaturity entails elevated intestinal epithelial TLR4 expression, because TLR4 is developmentally high in the fetal/preterm gut and is normally downregulated toward term.
→ node: Elevated Intestinal Epithelial TLR4 Expression
GO:0034142 (toll-like receptor 4 signaling pathway, validated)
"TLR4 expression in the premature intestine is increased compared with the full-term intestine" — PMID:17878380 [KB-VERIFIED] (model organism + human tissue)
3. Postnatal enteral feeding and NICU exposures (antibiotics, delayed/abnormal colonization) cause abnormal microbial colonization of that immature gut.
→ node: Abnormal Microbial Colonization of the Preterm Gut
ECTO:9001757 (validated exposure binding)
4. Abnormal colonization results in a Gammaproteobacterial (Enterobacteriaceae) bloom with loss of obligate anaerobes, which increases the luminal lipopolysaccharide load.
→ node: Gammaproteobacterial Bloom and Increased Luminal Lipopolysaccharide Load
CHEBI:16412 (lipopolysaccharide, validated)
"Gut dysbiosis, characterized by an increase in the relative abundance of Gammaproteobacteria, has been associated with NEC" — PMID:33328245 [KB-VERIFIED] (human clinical)
The functional-metagenomic enrichment of LPS O-antigen biosynthesis, type IV secretion, L-rhamnose utilization, quorum sensing and bacterial iron transport in pre-NEC samples supports this step being mechanistic rather than merely correlated. [INFERRED — the functional inference from gene-content enrichment to increased luminal LPS bioavailability is reasoned, not directly measured.]
⑂ The chain now forks. Both branches are required for full disease; each is individually demonstrated.
Branch A — the epithelial/inflammatory arm:
5A. Increased luminal LPS activates epithelial TLR4 beyond the threshold the immature epithelium can buffer (a threshold set lower still by SIGIRR loss-of-function where present).
→ node: Epithelial TLR4 Hyperactivation by Luminal Lipopolysaccharide
GO:0071222 (cellular response to lipopolysaccharide, validated); CL:0000584 (enterocyte, validated)
TLR4 is required: "TLR4-mutant C3H/HeJ mice were protected from the development of NEC" — from the TLR4-dependency literature, PMID:17878380 [KB-VERIFIED] (model organism)
6A. Epithelial TLR4 hyperactivation causes enterocyte apoptosis and simultaneously impairs the proliferation and migration that would restitute the mucosa — a dual hit in which injury rises while repair falls. This coupling is the mechanistic heart of NEC: TLR4 does not simply kill cells, it disables the healing response.
→ node: Enterocyte Apoptosis and Failed Mucosal Restitution
GO:0006915 (apoptotic process, validated); GO:0010631 (epithelial cell migration, validated); GO:0050673 (epithelial cell proliferation, validated)
"Toll-like receptor 4 inhibits enterocyte proliferation via impaired β-catenin signaling in necrotizing enterocolitis" — PMID:25899687 [KB-VERIFIED] (model organism + in vitro)
Single-cell transcriptomic atlases of human NEC intestine corroborate this at the tissue level: villus-tip epithelial loss, depletion of Paneth cell markers (DEFA6, GUCA2A), and ileal tuft cell depletion, alongside proinflammatory macrophage, fibroblast and endothelial states and TCRβ clonal expansion. [Human, but cross-sectional — the atlases describe established disease, so ordering within the chain is inferred.]
Branch B — the microvascular arm:
5B. In parallel, TLR4 signalling on endothelium (not epithelium) causes loss of eNOS-dependent vasodilation. This is the step that inverts the classical model: inflammation causes the ischemia.
→ nodes: Impaired Microcirculatory Autoregulation → Endothelial TLR4 Activation and Loss of eNOS-Dependent Vasodilation
CL:0002139 (endothelial cell of vascular tree, validated); GO:0006809 (nitric oxide biosynthetic process, validated); GO:0061028 (establishment of endothelial barrier, validated); UBERON:0001155/UBERON:0001168 (colon/ileum-region bindings, validated)
"Endothelial TLR4 activation impairs intestinal microcirculatory perfusion in necrotizing enterocolitis via eNOS-NO-nitrite signaling" — PMID:23650378 [KB-VERIFIED] (model organism)
6B. Loss of NO-mediated vasodilation, against unopposed endothelin-1 vasoconstriction, produces microcirculatory hypoperfusion and mucosal ischemia — concentrated at the villus tip, which is the watershed of the intestinal microcirculation and therefore the first tissue to infarct.
→ node: Microcirculatory Hypoperfusion and Mucosal Ischemia
GO:0001666 (response to hypoxia, validated); GO:0120193 (tight junction organization, validated)
Pharmacologic corroboration in the reverse direction: sildenafil (CHEBI:759884) — a PDE5 inhibitor potentiating NO-cGMP signalling — rescues the microcirculatory defect in the mouse model, and eNOS-null (Nos3⁻/⁻) mice show the predicted susceptibility. [MODEL]
⑂ The branches reconverge:
7. Epithelial death (6A) plus mucosal ischemia (6B) together cause barrier failure, permitting bacterial translocation across the mucosa.
→ node: Barrier Failure and Bacterial Translocation
GO:0120193 (tight junction organization, validated); UBERON:0001242 (intestinal mucosa, validated)
8. Translocated bacteria and LPS amplify mucosal proinflammatory cytokine production by lamina propria macrophages, dendritic cells, and recruited neutrophils — the point at which a local epithelial event becomes a tissue-destroying inflammatory one.
→ node: Mucosal Proinflammatory Cytokine Amplification
GO:0006954 (inflammatory response, validated); GO:0032640-family cytokine-production bindings (validated); CL:0000235 (macrophage, validated); CL:0000775 (neutrophil, validated); CL:0000115/CL:0002563 (validated cell bindings in entry)
This is also where the transfusion/anemia arm enters the chain: anemia primes intestinal macrophages, and RBC degradation products from transfusion activate them through TLR4 — a third TLR4-dependent input to the same amplification node, and the reason haptoglobin (which chelates the hemoglobin degradation products) is protective in the model. [MODEL; the human transfusion–NEC association is contested — see §2.5.]
9. Sustained inflammation plus ischemia cause coagulative necrosis of the mucosa; gas-forming organisms in the necrotic wall produce intramural gas — pneumatosis intestinalis, the radiographic signature of definite NEC.
→ node: Coagulative Mucosal Necrosis and Intramural Gas
HP:6000377 (pneumatosis-related binding, validated)
Coagulative necrosis is the histopathologic hallmark, and its presence distinguishes NEC from spontaneous intestinal perforation on pathology.
10. Necrosis progresses transmurally to full-thickness bowel wall destruction and causes perforation.
→ node: Transmural Necrosis and Perforation
HP:0031368 (intestinal perforation, validated)
11. Perforation and/or overwhelming translocation cause a systemic inflammatory response with sepsis, shock, DIC, and multi-organ failure. → node: Systemic Inflammatory Response and Sepsis
12. Systemic inflammation causes cerebral white matter injury in the developing brain — the mechanistic route from a gut disease to the long-term neurodevelopmental disability that dominates survivors' outcomes. → node: Cerebral White Matter Injury (terminal node) [INFERRED for the human causal step; the association is robust epidemiologically, and inflammatory white-matter injury is well-characterized mechanistically, but the specific NEC→white-matter causal link in humans rests on association plus mechanistic plausibility.]
Having given the chain, here is the detail organized against the template's requested categories, so nothing is missed:
Molecular mechanism. LPS–MD-2–TLR4 ligation → MyD88-dependent signalling → NF-κB activation → transcription of IL-6, IL-8/CXCL8, IL-1β, TNF. SIGIRR is the epithelium-enriched brake on this pathway; its loss lowers the activation threshold. TLR9 signalling is counter-regulatory (CpG-DNA-driven TLR9 signalling inhibits TLR4 in the intestine), which is one proposed mechanism for probiotic benefit. HMGB1 acts as an endogenous TLR4 ligand sustaining signalling after the initial LPS input. Separately, TLR4 inhibits enterocyte proliferation via impaired β-catenin signalling (PMID:25899687) — a Wnt-pathway crosstalk that is the specific molecular reason restitution fails.
Cellular mechanism. Enterocyte apoptosis (CL:0000584); loss of villus-tip epithelium; Paneth cell dysfunction with reduced antimicrobial peptide output (DEFA6, GUCA2A markers depleted); goblet cell/mucus deficiency; ileal tuft cell depletion (a 2023–2025 single-cell finding, mechanistically interesting because tuft cells sense luminal content and drive type 2 responses); macrophage activation and macrophage pyroptosis; neutrophil influx (CL:0000775); endothelial dysfunction (CL:0002139); fibroblast activation toward a proinflammatory state; TCRβ clonal expansion indicating an adaptive component in established lesions.
Tissue and organ mechanism. Terminal ileum and proximal colon are the predilection sites (UBERON:0001168 ileum-region, UBERON:0001155 colon, UBERON:0002108 small intestine, UBERON:0001242 intestinal mucosa). Injury begins at the mucosa and progresses outward — mucosal → submucosal → transmural. Pneumatosis reflects intramural gas in the necrotic wall; portal venous gas reflects its systemic tracking. Perforation is typically ileal.
Systemic mechanism. Bacterial translocation → bacteremia and sepsis; systemic cytokine release → shock, capillary leak, DIC, respiratory failure; systemic inflammation → cerebral white matter injury.
Compensatory/protective mechanisms that fail or are absent. Mucosal restitution (proliferation + migration) is actively inhibited by TLR4, not merely inadequate — this is the key point. NO-mediated vasodilatory autoregulation is lost. Paneth cell antimicrobial defence is immature. Secretory IgA is low. SIGIRR-mediated TLR4 inhibition is developmentally limited and, in some infants, genetically reduced. TLR9-mediated counter-regulation is a candidate protective axis that probiotics may engage.
Feedback loops. At least three amplifying loops operate: (i) epithelial death → more LPS access → more TLR4 signalling → more death; (ii) inflammation → hypoperfusion → ischemic epithelial death → more inflammation; (iii) HMGB1 release from dying cells → further TLR4 ligation. These positive-feedback loops are the mechanistic explanation for NEC's fulminant tempo.
| Level | Structure | Binding | Involvement |
|---|---|---|---|
| Organ | Small intestine | UBERON:0002108 (validated) | Primary |
| Organ region | Terminal ileum | UBERON:0001168 (validated ileum-region binding in entry) | Site of predilection; most common perforation site |
| Organ | Colon, esp. proximal/ascending | UBERON:0001155 (validated) | Frequently involved; ileocolic involvement is the classic distribution |
| Tissue | Intestinal mucosa | UBERON:0001242 (validated) | Where injury initiates |
| Tissue | Submucosa, muscularis, serosa | bindings not confirmed in this session | Progressive transmural involvement |
| Tissue | Intestinal microvasculature | see CL:0002139 for the cell |
Central to Branch B |
| Cell | Enterocyte | CL:0000584 (validated) | Apoptosis; failed restitution |
| Cell | Endothelial cell of vascular tree | CL:0002139 (validated) | TLR4-dependent loss of eNOS vasodilation |
| Cell | Macrophage | CL:0000235 (validated) | Cytokine amplification; pyroptosis; transfusion arm |
| Cell | Neutrophil | CL:0000775 (validated) | Tissue infiltration |
| Cell | Paneth cell | binding — the entry carries CL:0002563 and CL:0000115; confirm which is which |
Antimicrobial peptide deficiency |
| Cell | Goblet cell | not confirmed | Mucus deficiency |
| Cell | Tuft cell | not confirmed | Ileal depletion (single-cell finding) |
| Subcellular | Tight junction | GO:0120193 (tight junction organization — process, validated) | Barrier failure; note this is a GO-BP not a GO-CC binding |
| Subcellular | Plasma membrane TLR4 complex | GO-CC not bound in entry | Signal initiation |
Localization/distribution pattern. NEC is characteristically patchy and segmental, not diffuse — skip lesions are typical, and this patchiness is itself evidence for a microvascular watershed mechanism. The most severe form, NEC totalis, involves nearly the entire intestine and carries a near-uniformly fatal prognosis. Involvement is mucosa-outward at each affected segment.
One caveat on the two Paneth/other cell CURIEs: as in §3.2 and §4.8, CL:0000115 and CL:0002563 are confirmed present and validated in the committed entry but I cannot reliably assign their labels here. Read them from the entry.
Postnatal. NEC does not occur in utero. The distinctive feature, restated because it is mechanistically informative:
The inverse relationship between gestational age and postnatal age at onset means onset clusters at a relatively consistent postmenstrual age (roughly 29–33 weeks PMA), which is strong circumstantial evidence for a maturational-plus-colonization threshold rather than a fixed postnatal latency.
Variable and bimodal — this is clinically the defining problem. A substantial fraction resolves medically; a substantial fraction progresses to perforation within hours. There is no validated tool to predict which, which is why biomarker development (§10) is an active field and why the diagnostic window is the central unmet need.
For progression: curation, phase values along the lines of Prodrome / Established (Bell II) / Advanced (Bell III) / Resolution / Late complications map cleanly onto this.
Not Mendelian. See §4.1. The defensible statement is: multifactorial/complex, with polygenic susceptibility acting only within the environmentally-defined at-risk population of premature infants.
Do not assert a heritability estimate. The twin data are contradictory: some analyses report a raised co-twin risk, at least one formal ACE decomposition finds no detectable additive genetic variance once gestational age and shared intrauterine environment are accounted for, and the monochorionic-twin excess points to shared placental circulation rather than genotype. A curator should record this contradiction explicitly rather than pick a side — it is a good candidate for a discussions: entry with kind: KNOWLEDGE_GAP.
NEC incidence is best expressed per at-risk denominator, not per population:
For a prevalence: record, measure_type matters enormously here and is the commonest curation error in this disease. Most published NEC "rates" are period incidences within a birth-weight or gestational-age stratum, not population point prevalences. Use measure_type: PERIOD_PREVALENCE or ANNUAL_INCIDENCE as the source dictates, always set rate_denominator explicitly on any incidence record, and put the stratum in population: (e.g. "very-low-birth-weight infants, <1500 g"). Never use the qualitative COMMON/RARE tiers alongside a populated rate_per_100000.
Bell staging (original 1978, and its modified successors) remains the operational framework, with the caveats in §1.4. Diagnosis is clinical + radiographic; pneumatosis intestinalis on abdominal radiograph is the defining finding of definite (stage II) NEC.
"Based upon assessment of historical, clinical and radiographic findings, NEC was classified into three stages" — PMID:413500 [KB-VERIFIED] (human clinical)
| Modality | Findings | Binding |
|---|---|---|
| Abdominal radiograph (AP ± left lateral decubitus/cross-table lateral) — the first-line and defining test | Pneumatosis intestinalis (definite NEC); portal venous gas (severe); pneumoperitoneum (perforation → stage IIIB); fixed dilated loop; gasless abdomen | NCIT:C39608? — the entry carries NCIT:C39608; confirm its label before using it as the diagnostic-imaging binding |
| Abdominal ultrasound (increasingly used, arguably superior for some findings) | Bowel wall thickening/thinning, free fluid, portal venous gas, absent peristalsis, absent bowel-wall perfusion on Doppler — the last being the closest thing to direct visualization of the §6 Branch B mechanism | binding not confirmed |
| Near-infrared spectroscopy (NIRS) | Splanchnic tissue oxygenation; investigational for early detection | binding not confirmed |
| CT | Rarely used in neonates | — |
Abdominal ultrasound deserves specific mention: it detects portal venous gas and free fluid more sensitively than radiography and can assess bowel wall perfusion, which radiography cannot. Its uptake has been growing and it is a reasonable candidate for a definitions: or investigations: entry.
Non-specific but clinically decisive markers of severity:
- Thrombocytopenia (HP:0001873) — a falling platelet count is one of the most useful deterioration signals
- Metabolic acidosis — marker of tissue hypoperfusion and necrosis
- Neutropenia or neutrophilia; elevated immature-to-total neutrophil ratio
- Elevated CRP; hyponatremia; hyperglycemia; coagulopathy/DIC
- Blood culture — for bacteremia from translocation; positive in a minority
Biomarkers — investigational, none validated for clinical decision-making:
| Biomarker | Compartment | Rationale |
|---|---|---|
| I-FABP (intestinal fatty acid binding protein, FABP2) | Urine, serum | Released from dying enterocytes — a direct readout of the §6 step 6A node |
| Fecal calprotectin (S100A8/S100A9) | Stool | Neutrophilic intestinal inflammation |
| Fecal keratin 8 (KRT8) | Stool | Epithelial shedding |
| Human β-defensin 2 (DEFB4A) | Stool | Antimicrobial peptide response |
| Circulating microRNAs | Blood | Emerging |
| Metagenomic/metabolomic signatures | Stool | Pre-symptomatic risk stratification |
The honest summary: no biomarker has been validated to distinguish NEC from sepsis or feeding intolerance, or to predict progression, well enough for clinical use. This is the central unmet diagnostic need and belongs in the entry as an explicit knowledge gap.
Coagulative necrosis is the histopathologic hallmark, typically accompanied by inflammation, hemorrhage, and — in the appropriate setting — intramural gas and reparative changes. Its presence is the pathological feature distinguishing NEC from spontaneous intestinal perforation, which shows a focal perforation without the surrounding coagulative necrosis. Tissue is available only from resected specimens or autopsy, so histopathology confirms rather than establishes the diagnosis in life.
Not indicated. As set out in §4.7: no karyotype, CMA, FISH, mtDNA, or repeat-expansion testing has a role, and no gene panel or exome/genome test is clinically indicated for NEC. SIGIRR and other susceptibility-variant findings are research-domain only. This is a clear and curation-relevant negative.
| Entity | Discriminating features |
|---|---|
| Spontaneous intestinal perforation (SIP) | Earlier (first week), focal, no antecedent pneumatosis, no coagulative necrosis, often unfed. A separate disease — see §1.4. |
| Sepsis with ileus | No pneumatosis; no bloody stool |
| Feeding intolerance (benign) | No pneumatosis; resolves |
| Malrotation with volvulus | Bilious vomiting, surgical emergency, distinct radiography/upper GI |
| Hirschsprung-associated enterocolitis | Delayed meconium, history, rectal biopsy |
| Cow's milk protein allergy / allergic proctocolitis | More mature infants, blood-streaked stool, well appearance |
| Infectious enterocolitis | Organism-specific |
| Intestinal atresia | Congenital, presents with obstruction |
NEC is the leading cause of death from gastrointestinal disease in premature infants (PMID:35347256 [KB-VERIFIED]).
Mortality is starkly stratified by whether surgery is required:
HP:0001508)HP:0012758) — cognitive delay, cerebral palsy, visual and hearing impairment; markedly worse in surgical NEC survivors than gestational-age-matched controls. The mechanistic route is systemic inflammation → cerebral white matter injury (§6, step 12).| Factor | Direction |
|---|---|
| Need for surgery | ↓↓ prognosis (the strongest single discriminator) |
| Lower gestational age / birth weight | ↓ prognosis |
| Extent of bowel involvement (NEC totalis) | ↓↓ prognosis |
| Pneumoperitoneum / perforation | ↓ prognosis |
| Portal venous gas | ↓ prognosis |
| Shock, DIC, multi-organ failure | ↓ prognosis |
| Length of residual bowel; ileocecal valve preserved | ↑ prognosis |
| Human milk feeding | ↑ prognosis |
Untreated progressive NEC proceeds to transmural necrosis, perforation, peritonitis, septic shock, and death. There is no meaningful "untreated natural history" in contemporary practice, since even medical management (bowel rest, antibiotics, decompression, support) is universal — and a substantial fraction of NEC does resolve on that management alone, which is the reason a progression-prediction biomarker would be so valuable.
| Treatment | Description | treatment_term binding |
therapeutic_modality |
|---|---|---|---|
| Bowel rest / NPO + gastric decompression | Immediate cessation of enteral feeds; nasogastric decompression. The foundational intervention. | NCIT:C15620? — the entry carries NCIT:C15620; confirm label |
BEHAVIORAL or procedure, depending on label |
| Broad-spectrum parenteral antibiotics | Covering Gram-negatives and anaerobes; typically 7–14 days for stage II+ | NCIT:C15620/NCIT:C29484 — the entry carries both; confirm which is antibiotic therapy |
SMALL_MOLECULE |
| Parenteral nutrition | Nutritional support during bowel rest; prolonged in intestinal failure | NCIT:C15447 (dietary/nutritional intervention, validated) |
BEHAVIORAL — but see the CLAUDE.md warning against mechanically tagging nutritional support as BEHAVIORAL when the agent is a specific compound; PN is genuinely nutritional support, so BEHAVIORAL is defensible here |
| Cardiorespiratory and hemodynamic support | Volume, inotropes, mechanical ventilation | NCIT:C15747 (supportive care) — not confirmed as present in entry |
— |
| Transfusion support | Platelets, blood products, coagulopathy correction | not confirmed | — |
Note the iatrogenic tension worth recording in notes:: transfusion is both a treatment (for the coagulopathy and anemia of established NEC) and a putative risk factor for NEC onset (§2.3). The two are not contradictory — different timing, different context — but a curator should not let one erase the other.
| Intervention | Indication | Binding |
|---|---|---|
| Laparotomy with resection of necrotic bowel ± enterostomy | Perforation, clinical deterioration despite medical management, failure to improve | NCIT:C15329 (Surgical Procedure, validated) |
| Primary peritoneal drainage | Perforation, particularly in the smallest/most unstable infants | NCIT:C52005? — the entry carries NCIT:C52005; confirm label |
| Enterostomy (ileostomy/colostomy) with later reanastomosis | Standard after resection when primary anastomosis is unsafe | see NCIT:C15329 family |
| "Clip and drop" / staged laparotomy | Extensive multifocal disease | not bound |
The laparotomy vs. peritoneal drainage question is settled-ish and worth curating precisely. The NEST trial (Necrotizing Enterocolitis Surgery Trial, NCT01029353) randomized preterm infants with perforation to initial laparotomy vs initial peritoneal drainage. The broad finding across NEST and its predecessor trials is that initial approach does not produce a large difference in death or neurodevelopmental impairment, with the corollary that drainage is a legitimate option (including as temporizing measure) rather than an inferior one. I could not retrieve the NEST primary-outcome abstract verbatim in this session — a curator should just fetch-reference NCT01029353 and quote the registry record directly, plus fetch the primary publication, rather than relying on my characterization.
clinical_trials: record shape for this one:
clinical_trials:
- name: NCT01029353
phase: NOT_APPLICABLE # surgical strategy trial
status: COMPLETED
# evidence: quote the fetched clinicaltrials:NCT01029353 record
(Confirm phase/status against the fetched record; and note the CLAUDE.md warning that trial status: goes stale — run just clinicaltrials-status-audit on the file.)
None of these is standard care; all are mechanism-directed and map onto §6 nodes, which makes them good target_mechanisms candidates in the entry.
| Candidate | Mechanistic target (§6 node) | Status |
|---|---|---|
| TLR4 inhibitors (small molecules, C15-family compounds) | Epithelial TLR4 Hyperactivation | Preclinical |
Sildenafil (CHEBI:759884) |
Endothelial TLR4 Activation / Loss of eNOS-Dependent Vasodilation | Preclinical rescue in mouse model |
| Haptoglobin | Mucosal Proinflammatory Cytokine Amplification (transfusion arm) | Preclinical |
| Human milk oligosaccharides (isolated) | Gammaproteobacterial Bloom | Early clinical/preclinical |
| Lactoferrin | Abnormal Microbial Colonization | Large trials conducted (the ELFIN trial in the UK being the major one); the balance of evidence has not established benefit — I could not retrieve the primary publication verbatim and a curator should fetch it |
| Amniotic fluid / stem-cell-derived therapies | Enterocyte Apoptosis and Failed Mucosal Restitution | Preclinical |
| Bifidobacterium longum subsp. infantis (targeted, HMO-utilizing) | Abnormal Microbial Colonization | Clinical, contested (§13) |
| Fecal microbiota transplantation | Abnormal Microbial Colonization | Investigational; safety concerns in this population |
NCIT:C15238 (Gene Therapy), NCIT:C15240 (Genetic Counseling) and the gene/cell-therapy modalities should not appear in the entry.Genetic counseling specifically: not indicated for NEC, since there is no Mendelian risk to counsel about. Counseling regarding prematurity risk in future pregnancies is obstetric, not genetic, and is a different concern.
Prevention is where NEC care has genuinely advanced, and where the evidence is best.
(a) Human milk feeding — mother's own milk first.
Human milk feeding reduces NEC relative to formula, RR ≈ 0.62 — PMID:32384652 [SUMMARIZER-DERIVED] (human clinical, meta-analysis)
(b) Donor human milk when mother's own milk is unavailable.
Donor human milk vs formula reduces NEC, RR ≈ 0.53 — Cochrane 2024, PMID:39239939 [SUMMARIZER-DERIVED] (human clinical, systematic review)
An exclusive human milk diet (including human-milk-derived fortifier) is the logical extension and is practised in many units; the incremental benefit of human-milk-derived over bovine fortifier is less firmly established than the milk-vs-formula effect itself.
(c) Standardized feeding protocols. Unit-level standardization of feeding advancement reduces NEC in repeated quality-improvement series. Low cost, no plausible harm, and probably the highest-value intervention per unit of effort. Mechanism: avoids the rapid-advancement risk factor and reduces practice variation.
(d) Antibiotic stewardship. Limiting duration of early empiric antibiotics reduces subsequent NEC risk by preserving anaerobic colonization. Mechanism: directly targets the §6 step-3 node.
(e) Avoiding H2 blockers / PPIs in preterm infants unless clearly indicated.
(f) Antenatal corticosteroids — reduces prematurity morbidity broadly.
(g) Delayed cord clamping — improves hematologic status and has been associated with reduced NEC in some analyses. Moderate confidence.
This is the most important nuance in NEC prevention and must be curated as a controversy rather than a recommendation, because the trial evidence and the regulatory position point in opposite directions.
The trial evidence is favourable:
Probiotics reduce NEC (RR ≈ 0.54) and all-cause mortality (RR ≈ 0.77) in preterm infants — Cochrane 2023, PMID:37493095 [SUMMARIZER-DERIVED — re-quote before use] (human clinical, systematic review)
The regulatory position is cautionary. In 2023 the FDA issued a warning to healthcare providers about the use of probiotic products in preterm infants, following a case of fatal sepsis attributed to a probiotic organism in a preterm infant. The FDA's position is that these products are unapproved for this use and carry a risk of invasive infection by the administered organism.
Professional societies diverge, and did so before and after the FDA action: - AAP (2021) was cautious, declining to recommend routine probiotic administration to preterm infants, citing product-quality and regulatory concerns. - ESPGHAN, AGA, and WGO have issued positions more supportive of specific strains in specific populations.
The synthesis a curator should record: the aggregate randomized evidence supports a real NEC-prevention effect for some strains, while the product-quality, strain-identity, and invasive-infection risks are also real and are not addressed by the aggregate estimate. The effect is strain-specific and the trials are heterogeneous in strain, dose, and duration, so pooled estimates understate the strain-specificity. This is a legitimate discussions: entry, and it is the correct way to model the situation — not as "probiotics prevent NEC" nor as "probiotics are unsafe."
There is no established screening test for pre-symptomatic NEC. Candidate approaches — stool microbiome/metagenomic risk stratification, serial NIRS splanchnic oximetry, serial biomarkers — are all investigational. This is a major unmet need and the natural companion gap to the diagnostic gap in §10.3.
Avoid, where clinically possible: formula feeding, prolonged empiric antibiotics, acid suppression, rapid feeding advancement, unnecessary transfusion, hyperosmolar enteral medications. Achieve, where possible: mother's own milk, standardized feeding, antenatal steroids, delayed cord clamping.
NEC occurs naturally in animals, which is a genuinely useful and under-exploited fact. Two species matter:
(a) Neonatal piglets. Premature and neonatal piglets develop a spontaneous NEC-like disease, and this is the basis of the preterm piglet model (§15). Because the piglet is born relatively mature and can be delivered preterm by caesarean, the model reproduces the human sequence — prematurity + formula feeding + colonization — more faithfully than rodent models do. Naturally occurring NEC-like enteritis is also a recognized problem in commercial swine production.
(b) Neonatal foals. Necrotizing enterocolitis is a recognized clinical entity in neonatal foals, associated with prematurity, dysmaturity, perinatal asphyxia, and Clostridium involvement. It is treated in equine neonatal intensive care much as human NEC is.
Other species with relevant enteric necrotizing disease: calves (neonatal enteritis/enterotoxemia), puppies and kittens (neonatal enteritis), and rats/mice (only experimentally induced — see §15; spontaneous NEC in rodents is not described).
OMIA (Online Mendelian Inheritance in Animals): I could not retrieve an OMIA entry for NEC in any species in this session. Given that NEC is not Mendelian in humans, an OMIA entry is unlikely to exist, and its absence is expected rather than a gap in the search. Stated as unconfirmed.
The comparative picture is informative for mechanism:
NEC modelling is unusually good in one respect (the models reproduce the trigger combination, not just a lesion) and unusually poor in another (no model reproduces human prematurity).
Induction protocol: neonatal mice subjected to a combination of formula feeding (gavage), hypoxia, and hypothermia, sometimes with LPS or a bacterial inoculum. Reported incidence around 66% with the standard triple-insult protocol.
Fidelity: PARTIALLY_RECAPITULATES. It reproduces ileal coagulative necrosis, pneumatosis-like changes, epithelial apoptosis, and the TLR4 dependency. It does not reproduce prematurity — neonatal mice are term — which is the single largest divergence, since prematurity is the dominant human risk factor. This is a SPECIES_MISMATCH plus a substantial BOUNDARY_OMISSION: the initiating developmental condition of the human disease is absent, and the model substitutes hypoxia/hypothermia for it.
Key genetic strains and what each demonstrates:
| Strain | Finding | Which §6 node it addresses |
|---|---|---|
| C3H/HeJ (TLR4-mutant) | Protected from NEC — the foundational demonstration that TLR4 is required | Epithelial TLR4 Hyperactivation (necessity) |
| Intestinal-epithelium-specific Tlr4 deletion | Protected — localizes the requirement to epithelium | Epithelial TLR4 Hyperactivation (cell-type localization) |
| Endothelium-specific Tlr4 deletion | Protected — localizes a separate requirement to endothelium | Endothelial TLR4 Activation (Branch B) |
| Nos3⁻/⁻ (eNOS-null) | Increased susceptibility; impaired microcirculatory response | Loss of eNOS-Dependent Vasodilation |
| Sigirr-deficient / humanized SIGIRR-variant | Increased susceptibility — the mouse counterpart of the human genetic finding | Epithelial TLR4 Hyperactivation (threshold) |
| Sildenafil-treated | Rescued microcirculatory perfusion | Microcirculatory Hypoperfusion (pharmacologic reversal) |
| Haptoglobin-treated (transfusion model) | Protected | Cytokine Amplification (transfusion arm) |
The epithelium-vs-endothelium Tlr4 deletion pair is the strongest evidence in the whole field, because it shows the two §6 branches are separately necessary rather than one being a consequence of the other. A dismech modeled_mechanisms block should link each conditional knockout to its own branch node, with relationship: PERTURBS or RECAPITULATES as appropriate.
Evidence anchors: PMID:17878380 (TLR4 requirement, C3H/HeJ protection) and PMID:23650378 (endothelial TLR4/eNOS) are both [KB-VERIFIED] and both evidence_source: MODEL_ORGANISM.
Similar formula/hypoxia protocols; historically important and still used, particularly for feeding-intervention and probiotic studies. Same fidelity limitations as mouse, with less genetic tractability.
Induction: piglets delivered preterm by caesarean section and fed formula. The model referenced in the field as the HHF (or similar) piglet protocol.
Fidelity: the best available, and meaningfully better than rodent, because: - The animals are genuinely preterm — the dominant human risk factor is present rather than substituted - Pig gastrointestinal physiology, size, and milk composition are closer to human - The disease develops on formula feeding without requiring artificial hypoxia/hypothermia insults, so the trigger combination matches the human one - Size permits serial physiological measurement, surgery, and parenteral nutrition
Limitations: cost, facility requirements, limited genetic tools (no conditional knockouts comparable to mouse), and outbred genetics.
For curation: the piglet model should carry a higher fidelity value than the mouse model and a different limitations string, and the divergence types differ — the piglet's problem is POPULATION_MISMATCH/tooling, the mouse's is BOUNDARY_OMISSION (no prematurity).
experimental_models:)| System | Use | Notes |
|---|---|---|
| Human intestinal organoids / enteroids | TLR4 signalling, barrier function, epithelial apoptosis in human cells | Lacks immune, vascular, and microbial compartments — a BOUNDARY_OMISSION covering most of §6 |
| Human intestinal-epithelium-on-chip | Barrier, flow, host–microbe co-culture | Emerging |
| Human fetal/preterm intestinal tissue explants | Direct measurement of developmental TLR4 expression — the human anchor for §6 step 2 | Scarce tissue |
| IEC-6, Caco-2, T84 cell lines | Mechanistic dissection of TLR4/NF-κB/β-catenin signalling | Immortalized; evidence_source: IN_VITRO |
| Single-cell/spatial transcriptomics of human NEC intestine | Cell-state atlas of established disease | Human, cross-sectional — describes the endpoint, so causal ordering is inferred |
Note that human organoid and cell-line work must be graded IN_VITRO, and the single-cell atlases of surgical NEC specimens are HUMAN_CLINICAL.
I found no NEC-specific computational or systems-biology model (Boolean network, ODE, agent-based) in this session. This is a genuine gap and, given the multi-branch feedback structure of §6, NEC is an unusually good candidate for one — the three amplifying feedback loops identified in §6.2 are exactly the structure a Boolean or ODE model would illuminate. Stated as unavailable.
Primary human intestinal epithelial cells, human intestinal microvascular endothelial cells, and cord-blood-derived monocytes/macrophages are all used, principally to confirm in human cells the signalling relationships established in mouse. These are the right systems for closing the HUMAN_MODEL_MISMATCH gaps below.
Listing these so they are not silently taken as absent-because-negative:
Not retrieved in this session (a curator should look them up, not infer them): - OMIM, Orphanet, ICD-10-CM, ICD-11, MeSH, UMLS, DOID identifiers for NEC - gnomAD allele frequencies for the SIGIRR variants; HGVS-normalized variant nomenclature - ACMG classification for any NEC variant (none appears to exist) - HGNC IDs for any NEC gene - Per-phenotype frequency data suitable for HPO frequency qualifiers - Sex ratio; quantitative geographic distribution - The NEST trial primary-outcome publication; the ELFIN lactoferrin primary publication - A specific NEC epigenetics publication - An OMIA entry for NEC in any species - The current NEC definitional-consensus publication(s
) replacing Bell staging - Labels for five HP CURIEs, two CL CURIEs, two CHEBI CURIEs, and four NCIT CURIEs that are confirmed present in the validated entry but which I did not capture with a one-to-one label mapping
Genuinely contested in the literature (record as controversy, not as gap): - Heritability of NEC — co-twin risk elevation vs. null ACE decomposition vs. monochorionic-twin excess - Whether transfusion or the underlying anemia is the operative exposure in transfusion-associated NEC - Whether probiotics should be given routinely — favourable pooled RCT evidence vs. 2023 FDA warning vs. divergent society positions - Whether the reported racial disparity in NEC incidence reflects biology or the confounding of preterm-birth disparities, unit quality, and milk access - The case definition itself, and whether SIP is being systematically miscounted as NEC
Genuinely absent from the field (real knowledge gaps, suitable for discussions: entries):
- No validated biomarker to distinguish NEC from sepsis/feeding intolerance, or to predict progression
- No screening test for pre-symptomatic NEC
- No approved mechanism-directed therapy
- No computational/systems model of NEC
- No animal model that reproduces human prematurity (the mouse substitutes hypoxia/hypothermia; the piglet is preterm but has limited genetic tooling)
Correctly negative (assert these, don't leave them blank): - No Mendelian causal gene; no ClinGen gene–disease validity assertion - No chromosomal abnormality, CNV, or aneuploidy association - No role for karyotype, CMA, FISH, mtDNA, or repeat-expansion testing; no clinical indication for genetic testing at all - No somatic-mutation component - No single infectious agent as cause; NEC is not an infectious-disease entry - No vaccine; no gene, cell, RNA, or protein-replacement therapy; no enzyme replacement; no radiotherapy - No indication for genetic counseling on NEC-specific grounds - No teratogen or maternal toxin etiology - No founder-population or consanguinity relevance
Condensed, actionable notes for whoever populates the entry from this report.
Scope decisions
1. NEC is entry_type: DISEASE — a coherent clinical entity with a shared mechanism, not a grouping.
2. Spontaneous intestinal perforation is a separate disease. Do not absorb it. It is a reasonable stub candidate.
3. The infectious-disease granularity ladder (§3e) does not apply — NEC has no pathogen–syndrome pair, no infectious_agent, and just check-granularity should count it as out of scope rather than flag MISSING_AGENT.
4. The cancer ladder does not apply; there is no cell of origin to derive.
Pathophysiology
5. Use the 12-step chain in §6.1 as the node sequence. It is the sequence already committed in the entry, so conforms_to targets and bare-name downstream targets should match the existing node names exactly.
6. The chain branches at step 4 and reconverges at step 7. Model both branches; do not collapse Branch B into a consequence of Branch A — the conditional-knockout evidence (§15.1) shows they are separately necessary.
7. Set biological_scale: per node: steps 2, 4, 5A, 5B are MOLECULAR; 6A, 8 are CELLULAR; 6B, 7, 9, 10, 12 are TISSUE; 11 is ORGANISM. Step 1 is TISSUE. One value each — if a node wants two, it is bundling two claims and should split.
8. Steps 5A/5B are the right attaches_to targets for a SIGIRR gene–environment mechanistic_hypotheses entry.
Genetics
9. relationship_type: SUSCEPTIBILITY or RISK_FACTOR only. Never CAUSATIVE — the schema reserves it for Definitive/Strong ClinGen tiers and none exists.
10. Leave gene_disease_validity absent. Explain in Genetic.notes that no external body has classified any NEC gene pair. Do not assign a tier — there is no DISMECH value for classified_by, by design.
11. variant_origin: GERMLINE for any variant record.
12. Consider omitting inheritance: entirely rather than asserting HP:0010982 polygenic inheritance, given the contradictory twin data. If included, say why in the block description.
Environmental
13. Ten influences_mechanisms links are available (§5.1). Only TRIGGERS/EXACERBATES count for connectivity compliance — the four PREDISPOSES and two PROTECTS_AGAINST links will not connect a phenotype, which is correct and should not be worked around.
14. Each link needs its own evidence, separate from the environmental entry's entry-level evidence. check-environmental-evidence gates on the latter.
15. ECTO:9001757 is the one validated exposure binding. For the others — formula feeding, transfusion, antibiotics, acid suppression — run just environmental-term-audit and check the reuse candidates before concluding a term is absent. If ECTO genuinely lacks a term, record the verbatim queries run and what each returned, and re-run them immediately before committing the note. A false negative-existence claim is the one assertion no gate can reach.
Evidence
16. Reusable now, without further fetching: PMIDs 413500, 17878380, 23650378, 25899687, 33328245, 35347256 and the rest of the [KB-VERIFIED] set — their snippets are already validated in the entry.
17. Re-fetch and re-quote before using: PMIDs 37493095, 39239939, 32384652, 35554890. The figures (RR 0.54/0.77, RR 0.53, RR 0.62, 34,032 patients / 3.4% / 43.0%) are correct per retrieval, but the wording passed through summarization and is not confirmed exact. Run just fetch-reference PMID:<id> then just count-verified-snippets.
18. evidence_source grading for this disease: the TLR4/eNOS mechanism papers are MODEL_ORGANISM; the microbiome and single-cell papers are HUMAN_CLINICAL; cell-line and organoid work is IN_VITRO; Bell 1978 and the Cochrane reviews are HUMAN_CLINICAL. Note that PMID:17878380 reports both mouse and human tissue findings — split it into two evidence items rather than grading one item twice, per the mixed-source rule.
19. Watch quote_role: several mechanism papers state the human clinical picture in their introductions. A quote taken from a mouse paper's background paragraph asserting human epidemiology is evidence_source: HUMAN_CLINICAL + quote_role: BACKGROUND, not MODEL_ORGANISM and not OTHER. Run just list-background-citations on the file afterwards.
Terms
20. Re-read the entry for the ambiguous CURIEs before reusing them for a different slot: HP:0011968, HP:0001942, HP:0001396, HP:0001508, HP:0012758, CL:0000115, CL:0002563, CHEBI:28971, CHEBI:6909, NCIT:C39608, NCIT:C15620, NCIT:C29484, NCIT:C52005. All are confirmed present and enum-admissible; my label mapping for them is not reliable and must not be copied from this report.
21. Feeding intolerance has no good specific HPO term. If a coarse term is used, it needs a coarse_binding_basis — SOURCE_UNSPECIFIED is likely correct, since the sources describe a non-specific complex rather than declining to specify a known feature.
22. Cerebral white matter injury is modelled as a pathophysiology node, not a phenotype, in the committed entry. Keep it that way unless a curator deliberately changes the design.
Treatments
23. NCIT:C15329 (Surgical Procedure) and NCIT:C15447 (dietary/nutritional intervention) are the two treatment bindings I can state with confidence.
24. Antibiotic therapy needs therapeutic_agent — the treatment_term will be a generic pharmacotherapy action, so bind the agents or agent classes. Check admissibility against the ChemicalEntityTerm enum root NCIT:C1909 by running just validate-terms, not by grepping the enum cache (a cache miss means unknown, not excluded).
25. Record the transfusion tension in notes: — treatment in established disease, putative risk factor at onset. Both are true.
26. Run just clinicaltrials-status-audit after adding NCT01029353; status: and phase: are a snapshot and the cached trial records carry no retrieval timestamp.
Models
27. Mouse and piglet need different fidelity values and different divergences. Mouse: BOUNDARY_OMISSION (prematurity absent, substituted by hypoxia/hypothermia) + SPECIES_MISMATCH. Piglet: POPULATION_MISMATCH and tooling limits, but prematurity present — so higher fidelity.
28. The epithelium-specific and endothelium-specific Tlr4 knockouts should be separate modeled_mechanisms links to different nodes (5A and 5B respectively). That pairing is the single strongest piece of evidence in the field and collapsing it into one link loses the point.
29. model_scale for the mouse whole-organism model is ORGANISM; for organoids CELLULAR; for cell-line signalling work MOLECULAR. An organoid link to a TISSUE node is an upward extrapolation and requires limitations.
30. Set HUMAN_MODEL_MISMATCH (not KNOWLEDGE_GAP) on the prematurity problem: mouse evidence exists and is strong, but its translational validity is the open question. That is precisely the distinction the two kind values encode.
Prevalence
31. Most published NEC rates are period incidence within a birth-weight or gestational-age stratum, not population point prevalence. Put the stratum in population:, set measure_type to match the source, and set rate_denominator explicitly on any ANNUAL_INCIDENCE record (it has no fallback, by design). Never pair a qualitative COMMON/RARE tier with a populated rate_per_100000.
Knowledge gaps worth encoding as discussions:
32. Case definition contested → KNOWLEDGE_GAP, attaches_to: disease#
33. No progression-predicting biomarker → KNOWLEDGE_GAP, attaches_to: pathophysiology#Coagulative Mucosal Necrosis and Intramural Gas (the decision point)
34. No animal model reproduces prematurity → HUMAN_MODEL_MISMATCH, attaches_to: pathophysiology#Intestinal Immaturity of Prematurity
35. Heritability contradiction → KNOWLEDGE_GAP, attaches_to: genetic# or disease#
36. Probiotic evidence-vs-regulation divergence → KNOWLEDGE_GAP, attaches_to: treatments#
37. NEC→white-matter-injury human causal step inferred → KNOWLEDGE_GAP, attaches_to: pathophysiology#Cerebral White Matter Injury
Primary literature cited (PubMed)
Databases and registries
Regulatory and society positions
Repository sources (internal)
kb/disorders/Necrotizing_Enterocolitis.yaml — the committed, term-validated NEC entry (commit 40c038dd52); the source of every CURIE and every [KB-VERIFIED] snippet in this reportAll fifteen template sections are answered. Three things a reader should carry forward:
The chain in §6.1 is the deliverable. It is a 12-step ordered sequence with an explicit fork at step 4 and reconvergence at step 7, and it matches the node names already committed in the repository entry — so it can be used directly for downstream bare-name targets and conforms_to anchors without renaming anything.
The three-tier quotation labelling is not decoration. Six PMIDs are immediately usable as snippets; four carry figures that are right but wording that is not confirmed exact and must be re-fetched. Pasting a [SUMMARIZER-DERIVED] string as a snippet would produce a plausible-looking quote that fails linkml-reference-validator at best and passes while being a paraphrase at worst.
The thirteen ambiguous CURIEs in curation note 20 must be re-read from the entry. They are all real, validated, and enum-admissible — but supplying labels for them from this report would be exactly the reconstruct-from-memory failure the project forbids, which is why I marked them rather than filling them in. Under ten minutes of reading the committed file closes that gap completely.
Checked with linkml-reference-validator 0.3.0rc3.
| Outcome | Count |
|---|---|
| References checked | 27 |
| Resolved | 27 |
| Unresolved (possible confabulation) | 0 |
| Unverifiable | 0 |
| References weighed for topical relevance | 27 |
| On topic | 26 |
| Off topic | 0 |
All extracted references resolved successfully.
Checked with linkml-term-validator 0.4.5, through the ols: adapter.
| Outcome | Count |
|---|---|
| Terms checked | 58 |
| Resolved | 58 |
| Unresolved (possible confabulation) | 0 |
| Obsolete | 0 |
| Unverifiable | 0 |
| Terms whose name was checked | 3 |
| Terms named correctly | 0 |
| Terms named as a different term | 2 |
| Terms whose name is worth a second look | 1 |
These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:
MONDO:0005313 (7 mentions) - the report calls it "MONDO", "Monarch Initiative", "OLS/EBI"; MONDO calls it necrotizing enterocolitisHP:0006970 (1 mention) - the report calls it "Necrotizing enterocolitis (the disease as an HP feature)"; HP calls it Periventricular leukomalaciaThe report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:
HP:0003270 (1 mention) - the report calls it "Abdominal distension"; HP calls it Abdominal distention, and lists "Abdominal distension" among its other namesThe report gives these identifiers more than one name of its own:
MONDO:0005313 - called "MONDO", "Monarch Initiative", "OLS/EBI"